HRP20160678T1 - Derivati 2-(1,2,3-triazol-2-il)benzamida i 3-(1,2,3-triazol-2-il)pikolinamida kao antagonisti receptora oreksina - Google Patents
Derivati 2-(1,2,3-triazol-2-il)benzamida i 3-(1,2,3-triazol-2-il)pikolinamida kao antagonisti receptora oreksina Download PDFInfo
- Publication number
- HRP20160678T1 HRP20160678T1 HRP20160678TT HRP20160678T HRP20160678T1 HR P20160678 T1 HRP20160678 T1 HR P20160678T1 HR P20160678T T HRP20160678T T HR P20160678TT HR P20160678 T HRP20160678 T HR P20160678T HR P20160678 T1 HRP20160678 T1 HR P20160678T1
- Authority
- HR
- Croatia
- Prior art keywords
- triazol
- benzyl
- methanone
- phenyl
- morpholin
- Prior art date
Links
- TYWGXVSIWUAVQS-UHFFFAOYSA-N 2-(triazol-2-yl)benzamide Chemical compound NC(=O)C1=CC=CC=C1N1N=CC=N1 TYWGXVSIWUAVQS-UHFFFAOYSA-N 0.000 title 1
- XSQPATTVZNLZJE-UHFFFAOYSA-N 3-(triazol-2-yl)pyridine-2-carboxamide Chemical class NC(=O)C1=NC=CC=C1N1N=CC=N1 XSQPATTVZNLZJE-UHFFFAOYSA-N 0.000 title 1
- 229940123730 Orexin receptor antagonist Drugs 0.000 title 1
- 150000001875 compounds Chemical class 0.000 claims 17
- 150000003839 salts Chemical class 0.000 claims 16
- 229910052739 hydrogen Inorganic materials 0.000 claims 15
- 239000001257 hydrogen Substances 0.000 claims 15
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 15
- 150000002431 hydrogen Chemical class 0.000 claims 10
- 229910052736 halogen Inorganic materials 0.000 claims 9
- 150000002367 halogens Chemical class 0.000 claims 9
- -1 methoxy, hydroxy Chemical group 0.000 claims 8
- 125000000217 alkyl group Chemical group 0.000 claims 7
- 125000001153 fluoro group Chemical group F* 0.000 claims 6
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 5
- 125000003545 alkoxy group Chemical group 0.000 claims 5
- 125000001424 substituent group Chemical group 0.000 claims 5
- 125000004093 cyano group Chemical group *C#N 0.000 claims 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 4
- 125000001072 heteroaryl group Chemical group 0.000 claims 4
- 125000001309 chloro group Chemical group Cl* 0.000 claims 3
- 125000003709 fluoroalkyl group Chemical group 0.000 claims 3
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims 3
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims 3
- 208000019901 Anxiety disease Diseases 0.000 claims 2
- 208000027559 Appetite disease Diseases 0.000 claims 2
- 206010012335 Dependence Diseases 0.000 claims 2
- 208000019454 Feeding and Eating disease Diseases 0.000 claims 2
- 208000019022 Mood disease Diseases 0.000 claims 2
- 201000010099 disease Diseases 0.000 claims 2
- 208000035475 disorder Diseases 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 2
- 125000001715 oxadiazolyl group Chemical group 0.000 claims 2
- 125000002971 oxazolyl group Chemical group 0.000 claims 2
- 230000002265 prevention Effects 0.000 claims 2
- 125000003373 pyrazinyl group Chemical group 0.000 claims 2
- 125000003226 pyrazolyl group Chemical group 0.000 claims 2
- 125000002098 pyridazinyl group Chemical group 0.000 claims 2
- 125000004076 pyridyl group Chemical group 0.000 claims 2
- 125000000714 pyrimidinyl group Chemical group 0.000 claims 2
- 125000000168 pyrrolyl group Chemical group 0.000 claims 2
- 125000000335 thiazolyl group Chemical group 0.000 claims 2
- 125000001544 thienyl group Chemical group 0.000 claims 2
- 125000001425 triazolyl group Chemical group 0.000 claims 2
- 125000004950 trifluoroalkyl group Chemical group 0.000 claims 2
- BVVSWRIBSPAQPU-HXUWFJFHSA-N 4-(triazol-2-yl)-3-[(3r)-3-[[3-(triazol-2-yl)phenyl]methyl]morpholine-4-carbonyl]benzonitrile Chemical compound C([C@@H]1COCCN1C(=O)C=1C(=CC=C(C=1)C#N)N1N=CC=N1)C(C=1)=CC=CC=1N1N=CC=N1 BVVSWRIBSPAQPU-HXUWFJFHSA-N 0.000 claims 1
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical group C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 claims 1
- RRSNAFVMJVWFGD-NHCUHLMSSA-N [(2R,5R)-2-ethyl-5-[[3-(triazol-2-yl)phenyl]methyl]morpholin-4-yl]-[2-(triazol-2-yl)phenyl]methanone Chemical compound CC[C@@H]1CN([C@H](Cc2cccc(c2)-n2nccn2)CO1)C(=O)c1ccccc1-n1nccn1 RRSNAFVMJVWFGD-NHCUHLMSSA-N 0.000 claims 1
- UJDZZHFYTLBQSA-FGZHOGPDSA-N [(2R,5R)-2-ethyl-5-[[3-(triazol-2-yl)phenyl]methyl]morpholin-4-yl]-[4-methyl-2-(triazol-2-yl)phenyl]methanone Chemical compound C(C)[C@@H]1CN([C@@H](CO1)CC1=CC(=CC=C1)N1N=CC=N1)C(=O)C1=C(C=C(C=C1)C)N1N=CC=N1 UJDZZHFYTLBQSA-FGZHOGPDSA-N 0.000 claims 1
- SBZFLVKAWPYIDI-FGZHOGPDSA-N [(2R,5R)-2-ethyl-5-[[3-(triazol-2-yl)phenyl]methyl]morpholin-4-yl]-[5-methyl-2-(triazol-2-yl)phenyl]methanone Chemical compound C(C)[C@@H]1CN([C@@H](CO1)CC1=CC(=CC=C1)N1N=CC=N1)C(=O)C1=C(C=CC(=C1)C)N1N=CC=N1 SBZFLVKAWPYIDI-FGZHOGPDSA-N 0.000 claims 1
- GTTJINSRAWFIHD-WIYYLYMNSA-N [(2R,5R)-2-methyl-5-[(3-pyrimidin-2-ylphenyl)methyl]morpholin-4-yl]-[2-(triazol-2-yl)phenyl]methanone Chemical compound C[C@@H]1CN([C@@H](CO1)CC1=CC(=CC=C1)C1=NC=CC=N1)C(=O)C1=C(C=CC=C1)N1N=CC=N1 GTTJINSRAWFIHD-WIYYLYMNSA-N 0.000 claims 1
- QDURYEZFCXJVOM-DENIHFKCSA-N [(2R,5R)-2-methyl-5-[(3-pyrimidin-2-ylphenyl)methyl]morpholin-4-yl]-[3-methyl-2-(triazol-2-yl)phenyl]methanone Chemical compound C[C@@H]1CN([C@@H](CO1)CC1=CC(=CC=C1)C1=NC=CC=N1)C(=O)C1=C(C(=CC=C1)C)N1N=CC=N1 QDURYEZFCXJVOM-DENIHFKCSA-N 0.000 claims 1
- STINWRWRNQHPGO-DENIHFKCSA-N [(2R,5R)-2-methyl-5-[(3-pyrimidin-2-ylphenyl)methyl]morpholin-4-yl]-[4-methyl-2-(triazol-2-yl)phenyl]methanone Chemical compound C[C@@H]1CN([C@@H](CO1)CC1=CC(=CC=C1)C1=NC=CC=N1)C(=O)C1=C(C=C(C=C1)C)N1N=CC=N1 STINWRWRNQHPGO-DENIHFKCSA-N 0.000 claims 1
- ACKAOVNXPNOWIE-DENIHFKCSA-N [(2R,5R)-2-methyl-5-[(3-pyrimidin-2-ylphenyl)methyl]morpholin-4-yl]-[5-methyl-2-(triazol-2-yl)phenyl]methanone Chemical compound C[C@@H]1CN([C@H](Cc2cccc(c2)-c2ncccn2)CO1)C(=O)c1cc(C)ccc1-n1nccn1 ACKAOVNXPNOWIE-DENIHFKCSA-N 0.000 claims 1
- OAHUTLZBMNCBFN-WIYYLYMNSA-N [(2R,5R)-5-[(2-fluoro-5-pyridazin-3-ylphenyl)methyl]-2-methylmorpholin-4-yl]-[4-methyl-2-(triazol-2-yl)phenyl]methanone Chemical compound FC1=C(C[C@@H]2CO[C@@H](CN2C(=O)C2=C(C=C(C=C2)C)N2N=CC=N2)C)C=C(C=C1)C=1N=NC=CC1 OAHUTLZBMNCBFN-WIYYLYMNSA-N 0.000 claims 1
- STUGMTDSOKPRBQ-WIYYLYMNSA-N [(2R,5R)-5-[(2-fluoro-5-pyrimidin-2-ylphenyl)methyl]-2-methylmorpholin-4-yl]-[3-methyl-2-(triazol-2-yl)phenyl]methanone Chemical compound C[C@@H]1CN([C@H](Cc2cc(ccc2F)-c2ncccn2)CO1)C(=O)c1cccc(C)c1-n1nccn1 STUGMTDSOKPRBQ-WIYYLYMNSA-N 0.000 claims 1
- HYSRABRBUHZYQJ-WIYYLYMNSA-N [(2R,5R)-5-[(2-fluoro-5-pyrimidin-2-ylphenyl)methyl]-2-methylmorpholin-4-yl]-[4-methyl-2-(triazol-2-yl)phenyl]methanone Chemical compound FC1=C(C[C@@H]2CO[C@@H](CN2C(=O)C2=C(C=C(C=C2)C)N2N=CC=N2)C)C=C(C=C1)C1=NC=CC=N1 HYSRABRBUHZYQJ-WIYYLYMNSA-N 0.000 claims 1
- AEIDDRZWBROWDG-WIYYLYMNSA-N [(2R,5R)-5-[(2-fluoro-5-pyrimidin-2-ylphenyl)methyl]-2-methylmorpholin-4-yl]-[5-methyl-2-(triazol-2-yl)phenyl]methanone Chemical compound FC1=C(C[C@@H]2CO[C@@H](CN2C(=O)C2=C(C=CC(=C2)C)N2N=CC=N2)C)C=C(C=C1)C1=NC=CC=N1 AEIDDRZWBROWDG-WIYYLYMNSA-N 0.000 claims 1
- OSHBRXGINANDJA-YLJYHZDGSA-N [(2R,5R)-5-[[2-fluoro-5-(triazol-1-yl)phenyl]methyl]-2-methylmorpholin-4-yl]-[5-methyl-2-(triazol-2-yl)phenyl]methanone Chemical compound FC1=C(C[C@@H]2CO[C@@H](CN2C(=O)C2=C(C=CC(=C2)C)N2N=CC=N2)C)C=C(C=C1)N1N=NC=C1 OSHBRXGINANDJA-YLJYHZDGSA-N 0.000 claims 1
- SNOAPCQTEZAFRK-VQIMIIECSA-N [(2R,5R)-5-[[2-fluoro-5-(triazol-2-yl)phenyl]methyl]-2-methylmorpholin-4-yl]-[2-(triazol-2-yl)phenyl]methanone Chemical compound FC1=C(C[C@@H]2CO[C@@H](CN2C(=O)C2=C(C=CC=C2)N2N=CC=N2)C)C=C(C=C1)N1N=CC=N1 SNOAPCQTEZAFRK-VQIMIIECSA-N 0.000 claims 1
- QOXZYZJSLRTDNB-YLJYHZDGSA-N [(2R,5R)-5-[[2-fluoro-5-(triazol-2-yl)phenyl]methyl]-2-methylmorpholin-4-yl]-[3-methyl-2-(triazol-2-yl)phenyl]methanone Chemical compound FC1=C(C[C@@H]2CO[C@@H](CN2C(=O)C2=C(C(=CC=C2)C)N2N=CC=N2)C)C=C(C=C1)N1N=CC=N1 QOXZYZJSLRTDNB-YLJYHZDGSA-N 0.000 claims 1
- MRMSRUZHMOGZGF-YLJYHZDGSA-N [(2R,5R)-5-[[2-fluoro-5-(triazol-2-yl)phenyl]methyl]-2-methylmorpholin-4-yl]-[4-methyl-2-(triazol-2-yl)phenyl]methanone Chemical compound FC1=C(C[C@@H]2CO[C@@H](CN2C(=O)C2=C(C=C(C=C2)C)N2N=CC=N2)C)C=C(C=C1)N1N=CC=N1 MRMSRUZHMOGZGF-YLJYHZDGSA-N 0.000 claims 1
- IEJDUPAJXHWTNS-YLJYHZDGSA-N [(2R,5R)-5-[[2-fluoro-5-(triazol-2-yl)phenyl]methyl]-2-methylmorpholin-4-yl]-[5-methyl-2-(triazol-2-yl)phenyl]methanone Chemical compound FC1=C(C[C@@H]2CO[C@@H](CN2C(=O)C2=C(C=CC(=C2)C)N2N=CC=N2)C)C=C(C=C1)N1N=CC=N1 IEJDUPAJXHWTNS-YLJYHZDGSA-N 0.000 claims 1
- QWFXFQGJPGRBQR-YLJYHZDGSA-N [(2r,5r)-2-methyl-5-[[3-(triazol-2-yl)phenyl]methyl]morpholin-4-yl]-[2-(triazol-2-yl)phenyl]methanone Chemical compound C([C@H]1N(C[C@H](OC1)C)C(=O)C=1C(=CC=CC=1)N1N=CC=N1)C(C=1)=CC=CC=1N1N=CC=N1 QWFXFQGJPGRBQR-YLJYHZDGSA-N 0.000 claims 1
- CWXMVKZSRVPZAO-YLJYHZDGSA-N [(2r,5r)-5-[(2-fluoro-5-pyrimidin-2-ylphenyl)methyl]-2-methylmorpholin-4-yl]-[2-(triazol-2-yl)phenyl]methanone Chemical compound C([C@H]1N(C[C@H](OC1)C)C(=O)C=1C(=CC=CC=1)N1N=CC=N1)C(C(=CC=1)F)=CC=1C1=NC=CC=N1 CWXMVKZSRVPZAO-YLJYHZDGSA-N 0.000 claims 1
- BLNLRXMYYDRXJH-YLJYHZDGSA-N [(2r,5r)-5-[[2-fluoro-5-(triazol-1-yl)phenyl]methyl]-2-methylmorpholin-4-yl]-[4-methyl-2-(triazol-2-yl)phenyl]methanone Chemical compound C([C@H]1N(C[C@H](OC1)C)C(=O)C=1C(=CC(C)=CC=1)N1N=CC=N1)C(C(=CC=1)F)=CC=1N1C=CN=N1 BLNLRXMYYDRXJH-YLJYHZDGSA-N 0.000 claims 1
- OBGUWOPMHXCGQJ-GOSISDBHSA-N [(3R)-3-[(4-hydroxy-3-pyrimidin-2-ylphenyl)methyl]morpholin-4-yl]-[2-(triazol-2-yl)phenyl]methanone Chemical compound Oc1ccc(C[C@@H]2COCCN2C(=O)c2ccccc2-n2nccn2)cc1-c1ncccn1 OBGUWOPMHXCGQJ-GOSISDBHSA-N 0.000 claims 1
- RDSLXYSTWOTMMZ-HXUWFJFHSA-N [(3R)-3-[(4-methyl-3-pyrimidin-2-ylphenyl)methyl]morpholin-4-yl]-[2-(triazol-2-yl)phenyl]methanone Chemical compound CC1=C(C=C(C[C@H]2N(CCOC2)C(=O)C2=C(C=CC=C2)N2N=CC=N2)C=C1)C1=NC=CC=N1 RDSLXYSTWOTMMZ-HXUWFJFHSA-N 0.000 claims 1
- BAHLPIRZKQNNOE-GOSISDBHSA-N [(3R)-3-[[2-chloro-5-(triazol-2-yl)phenyl]methyl]morpholin-4-yl]-[2-(triazol-2-yl)phenyl]methanone Chemical compound ClC1=C(C[C@H]2N(CCOC2)C(=O)C2=C(C=CC=C2)N2N=CC=N2)C=C(C=C1)N1N=CC=N1 BAHLPIRZKQNNOE-GOSISDBHSA-N 0.000 claims 1
- KJPCUIQPIJYTDA-HXUWFJFHSA-N [(3R)-3-[[2-chloro-5-(triazol-2-yl)phenyl]methyl]morpholin-4-yl]-[3,4-dimethyl-2-(triazol-2-yl)phenyl]methanone Chemical compound Cc1ccc(C(=O)N2CCOC[C@H]2Cc2cc(ccc2Cl)-n2nccn2)c(c1C)-n1nccn1 KJPCUIQPIJYTDA-HXUWFJFHSA-N 0.000 claims 1
- FIPXBPYXRCPALA-LJQANCHMSA-N [(3R)-3-[[2-chloro-5-(triazol-2-yl)phenyl]methyl]morpholin-4-yl]-[3-methyl-2-(triazol-2-yl)phenyl]methanone Chemical compound Cc1cccc(C(=O)N2CCOC[C@H]2Cc2cc(ccc2Cl)-n2nccn2)c1-n1nccn1 FIPXBPYXRCPALA-LJQANCHMSA-N 0.000 claims 1
- PHEQMGRTEIENAJ-LJQANCHMSA-N [(3R)-3-[[2-chloro-5-(triazol-2-yl)phenyl]methyl]morpholin-4-yl]-[4-methyl-2-(triazol-2-yl)phenyl]methanone Chemical compound Cc1ccc(C(=O)N2CCOC[C@H]2Cc2cc(ccc2Cl)-n2nccn2)c(c1)-n1nccn1 PHEQMGRTEIENAJ-LJQANCHMSA-N 0.000 claims 1
- HZYFRDSVQFDLHM-LJQANCHMSA-N [(3R)-3-[[2-chloro-5-(triazol-2-yl)phenyl]methyl]morpholin-4-yl]-[5-methyl-2-(triazol-2-yl)phenyl]methanone Chemical compound ClC1=C(C[C@H]2N(CCOC2)C(=O)C2=C(C=CC(=C2)C)N2N=CC=N2)C=C(C=C1)N1N=CC=N1 HZYFRDSVQFDLHM-LJQANCHMSA-N 0.000 claims 1
- YNLXALPSUPUEOW-GOSISDBHSA-N [(3R)-3-[[2-fluoro-3-(triazol-2-yl)phenyl]methyl]morpholin-4-yl]-[4-methyl-2-(triazol-2-yl)phenyl]methanone Chemical compound FC1=C(C[C@H]2N(CCOC2)C(=O)C2=C(C=C(C=C2)C)N2N=CC=N2)C=CC=C1N1N=CC=N1 YNLXALPSUPUEOW-GOSISDBHSA-N 0.000 claims 1
- HYFRBSMLWUEXKY-GOSISDBHSA-N [(3R)-3-[[2-fluoro-5-(triazol-2-yl)phenyl]methyl]morpholin-4-yl]-[2-(triazol-2-yl)-4-(trifluoromethyl)phenyl]methanone Chemical compound Fc1ccc(cc1C[C@@H]1COCCN1C(=O)c1ccc(cc1-n1nccn1)C(F)(F)F)-n1nccn1 HYFRBSMLWUEXKY-GOSISDBHSA-N 0.000 claims 1
- IKDFBCDOUXZRDH-LJQANCHMSA-N [(3R)-3-[[2-fluoro-5-(triazol-2-yl)phenyl]methyl]morpholin-4-yl]-[3-methyl-2-(triazol-2-yl)phenyl]methanone Chemical compound Cc1cccc(C(=O)N2CCOC[C@H]2Cc2cc(ccc2F)-n2nccn2)c1-n1nccn1 IKDFBCDOUXZRDH-LJQANCHMSA-N 0.000 claims 1
- JBGQDYPWYFNNTI-GOSISDBHSA-N [(3R)-3-[[2-fluoro-5-(triazol-2-yl)phenyl]methyl]morpholin-4-yl]-[5-methoxy-2-(triazol-2-yl)phenyl]methanone Chemical compound COc1ccc(c(c1)C(=O)N1CCOC[C@H]1Cc1cc(ccc1F)-n1nccn1)-n1nccn1 JBGQDYPWYFNNTI-GOSISDBHSA-N 0.000 claims 1
- BNXAFMJKKZGLDN-LJQANCHMSA-N [(3R)-3-[[2-fluoro-5-(triazol-2-yl)phenyl]methyl]morpholin-4-yl]-[5-methoxy-4-methyl-2-(triazol-2-yl)phenyl]methanone Chemical compound COc1cc(C(=O)N2CCOC[C@H]2Cc2cc(ccc2F)-n2nccn2)c(cc1C)-n1nccn1 BNXAFMJKKZGLDN-LJQANCHMSA-N 0.000 claims 1
- SKTHZCLPOHWFMH-HXUWFJFHSA-N [(3R)-3-[[2-methyl-5-(triazol-2-yl)phenyl]methyl]morpholin-4-yl]-[2-(triazol-2-yl)phenyl]methanone Chemical compound CC1=C(C[C@H]2N(CCOC2)C(=O)C2=C(C=CC=C2)N2N=CC=N2)C=C(C=C1)N1N=CC=N1 SKTHZCLPOHWFMH-HXUWFJFHSA-N 0.000 claims 1
- KJXCOZMMUXZQGE-GOSISDBHSA-N [(3R)-3-[[3-(triazol-2-yl)phenyl]methyl]morpholin-4-yl]-[2-(triazol-2-yl)-3-(trifluoromethyl)phenyl]methanone Chemical compound FC(F)(F)c1cccc(C(=O)N2CCOC[C@H]2Cc2cccc(c2)-n2nccn2)c1-n1nccn1 KJXCOZMMUXZQGE-GOSISDBHSA-N 0.000 claims 1
- PNBXBOOTVNVZSH-LJQANCHMSA-N [(3R)-3-[[3-fluoro-5-(triazol-2-yl)phenyl]methyl]morpholin-4-yl]-[2-(triazol-2-yl)phenyl]methanone Chemical compound FC=1C=C(C[C@H]2N(CCOC2)C(=O)C2=C(C=CC=C2)N2N=CC=N2)C=C(C1)N1N=CC=N1 PNBXBOOTVNVZSH-LJQANCHMSA-N 0.000 claims 1
- JOKDLAIJHCOJRF-HXUWFJFHSA-N [(3R)-3-[[3-fluoro-5-(triazol-2-yl)phenyl]methyl]morpholin-4-yl]-[4-methyl-2-(triazol-2-yl)phenyl]methanone Chemical compound FC=1C=C(C[C@H]2N(CCOC2)C(=O)C2=C(C=C(C=C2)C)N2N=CC=N2)C=C(C1)N1N=CC=N1 JOKDLAIJHCOJRF-HXUWFJFHSA-N 0.000 claims 1
- KDSFEYCWXQWBSK-HXUWFJFHSA-N [(3r)-3-[(2-fluoro-5-pyridazin-3-ylphenyl)methyl]morpholin-4-yl]-[4-methyl-2-(triazol-2-yl)phenyl]methanone Chemical compound C([C@@H]1COCCN1C(=O)C1=CC=C(C=C1N1N=CC=N1)C)C(C(=CC=1)F)=CC=1C1=CC=CN=N1 KDSFEYCWXQWBSK-HXUWFJFHSA-N 0.000 claims 1
- VLMPYJVCPJRPBH-HXUWFJFHSA-N [(3r)-3-[(2-fluoro-5-pyrimidin-2-ylphenyl)methyl]morpholin-4-yl]-[3-methyl-2-(triazol-2-yl)phenyl]methanone Chemical compound C([C@@H]1COCCN1C(=O)C=1C=CC=C(C=1N1N=CC=N1)C)C(C(=CC=1)F)=CC=1C1=NC=CC=N1 VLMPYJVCPJRPBH-HXUWFJFHSA-N 0.000 claims 1
- LUSDGIQGCBLNQS-HXUWFJFHSA-N [(3r)-3-[(2-fluoro-5-pyrimidin-2-ylphenyl)methyl]morpholin-4-yl]-[4-methyl-2-(triazol-2-yl)phenyl]methanone Chemical compound C([C@@H]1COCCN1C(=O)C1=CC=C(C=C1N1N=CC=N1)C)C(C(=CC=1)F)=CC=1C1=NC=CC=N1 LUSDGIQGCBLNQS-HXUWFJFHSA-N 0.000 claims 1
- QIKVTMHZHYXNDE-HXUWFJFHSA-N [(3r)-3-[(2-fluoro-5-pyrimidin-2-ylphenyl)methyl]morpholin-4-yl]-[5-methyl-2-(triazol-2-yl)phenyl]methanone Chemical compound C([C@@H]1COCCN1C(=O)C=1C(=CC=C(C=1)C)N1N=CC=N1)C(C(=CC=1)F)=CC=1C1=NC=CC=N1 QIKVTMHZHYXNDE-HXUWFJFHSA-N 0.000 claims 1
- LZJVNRGGFLKPHX-JOCHJYFZSA-N [(3r)-3-[(2-methyl-5-pyrazol-1-ylphenyl)methyl]morpholin-4-yl]-[3-methyl-2-(triazol-2-yl)phenyl]methanone Chemical compound C([C@H]1CC2=CC(=CC=C2C)N2N=CC=C2)OCCN1C(=O)C1=CC=CC(C)=C1N1N=CC=N1 LZJVNRGGFLKPHX-JOCHJYFZSA-N 0.000 claims 1
- ZVAZIIXJYBKGIK-JOCHJYFZSA-N [(3r)-3-[(2-methyl-5-pyrazol-1-ylphenyl)methyl]morpholin-4-yl]-[4-methyl-2-(triazol-2-yl)phenyl]methanone Chemical compound C([C@@H]1COCCN1C(=O)C1=CC=C(C=C1N1N=CC=N1)C)C(C(=CC=1)C)=CC=1N1C=CC=N1 ZVAZIIXJYBKGIK-JOCHJYFZSA-N 0.000 claims 1
- WOWXUSLEOFOYDZ-JOCHJYFZSA-N [(3r)-3-[(2-methyl-5-pyrazol-1-ylphenyl)methyl]morpholin-4-yl]-[5-methyl-2-(triazol-2-yl)phenyl]methanone Chemical compound C([C@@H]1COCCN1C(=O)C=1C(=CC=C(C=1)C)N1N=CC=N1)C(C(=CC=1)C)=CC=1N1C=CC=N1 WOWXUSLEOFOYDZ-JOCHJYFZSA-N 0.000 claims 1
- NSPDBKKKFMEMRB-HXUWFJFHSA-N [(3r)-3-[(3-pyrazol-1-ylphenyl)methyl]morpholin-4-yl]-[2-(triazol-2-yl)phenyl]methanone Chemical compound C([C@@H]1COCCN1C(=O)C=1C(=CC=CC=1)N1N=CC=N1)C(C=1)=CC=CC=1N1C=CC=N1 NSPDBKKKFMEMRB-HXUWFJFHSA-N 0.000 claims 1
- FYQCTNQQQSRWPV-HXUWFJFHSA-N [(3r)-3-[(3-pyridazin-3-ylphenyl)methyl]morpholin-4-yl]-[2-(triazol-2-yl)phenyl]methanone Chemical compound C([C@@H]1COCCN1C(=O)C=1C(=CC=CC=1)N1N=CC=N1)C(C=1)=CC=CC=1C1=CC=CN=N1 FYQCTNQQQSRWPV-HXUWFJFHSA-N 0.000 claims 1
- RHBCBAZYIYZIMR-HXUWFJFHSA-N [(3r)-3-[(3-pyrimidin-2-ylphenyl)methyl]morpholin-4-yl]-[2-(triazol-2-yl)phenyl]methanone Chemical compound C([C@@H]1COCCN1C(=O)C=1C(=CC=CC=1)N1N=CC=N1)C(C=1)=CC=CC=1C1=NC=CC=N1 RHBCBAZYIYZIMR-HXUWFJFHSA-N 0.000 claims 1
- YHWXLTYWQSZIKW-HXUWFJFHSA-N [(3r)-3-[(3-thiophen-2-ylphenyl)methyl]morpholin-4-yl]-[2-(triazol-2-yl)phenyl]methanone Chemical compound C([C@@H]1COCCN1C(=O)C=1C(=CC=CC=1)N1N=CC=N1)C(C=1)=CC=CC=1C1=CC=CS1 YHWXLTYWQSZIKW-HXUWFJFHSA-N 0.000 claims 1
- AKVDRUIVHSDXNM-GOSISDBHSA-N [(3r)-3-[(4-chloro-3-pyrimidin-2-ylphenyl)methyl]morpholin-4-yl]-[2-(triazol-2-yl)phenyl]methanone Chemical compound C([C@H]1CC2=CC=C(C(=C2)C=2N=CC=CN=2)Cl)OCCN1C(=O)C1=CC=CC=C1N1N=CC=N1 AKVDRUIVHSDXNM-GOSISDBHSA-N 0.000 claims 1
- CZERAVZVKNLXOP-LJQANCHMSA-N [(3r)-3-[(4-methoxy-3-pyrazin-2-ylphenyl)methyl]morpholin-4-yl]-[2-(triazol-2-yl)phenyl]methanone Chemical compound C([C@H]1CC2=CC=C(C(=C2)C=2N=CC=NC=2)OC)OCCN1C(=O)C1=CC=CC=C1N1N=CC=N1 CZERAVZVKNLXOP-LJQANCHMSA-N 0.000 claims 1
- HZTIXYMNAITACJ-LJQANCHMSA-N [(3r)-3-[(4-methoxy-3-pyrazol-1-ylphenyl)methyl]morpholin-4-yl]-[2-(triazol-2-yl)phenyl]methanone Chemical compound C([C@H]1CC2=CC=C(C(=C2)N2N=CC=C2)OC)OCCN1C(=O)C1=CC=CC=C1N1N=CC=N1 HZTIXYMNAITACJ-LJQANCHMSA-N 0.000 claims 1
- FURKPFKLIIWSMR-LJQANCHMSA-N [(3r)-3-[(4-methoxy-3-pyridazin-3-ylphenyl)methyl]morpholin-4-yl]-[2-(triazol-2-yl)phenyl]methanone Chemical compound C([C@H]1CC2=CC=C(C(=C2)C=2N=NC=CC=2)OC)OCCN1C(=O)C1=CC=CC=C1N1N=CC=N1 FURKPFKLIIWSMR-LJQANCHMSA-N 0.000 claims 1
- KKEOYRYRWVSPJZ-HXUWFJFHSA-N [(3r)-3-[(4-methoxy-3-pyridin-2-ylphenyl)methyl]morpholin-4-yl]-[2-(triazol-2-yl)phenyl]methanone Chemical compound C([C@H]1CC2=CC=C(C(=C2)C=2N=CC=CC=2)OC)OCCN1C(=O)C1=CC=CC=C1N1N=CC=N1 KKEOYRYRWVSPJZ-HXUWFJFHSA-N 0.000 claims 1
- OLMUIMIZDWOYII-OAQYLSRUSA-N [(3r)-3-[(4-methoxy-3-pyridin-3-ylphenyl)methyl]morpholin-4-yl]-[2-(triazol-2-yl)phenyl]methanone Chemical compound C([C@H]1CC2=CC=C(C(=C2)C=2C=NC=CC=2)OC)OCCN1C(=O)C1=CC=CC=C1N1N=CC=N1 OLMUIMIZDWOYII-OAQYLSRUSA-N 0.000 claims 1
- OREIPZHDUFKPTP-LJQANCHMSA-N [(3r)-3-[(4-methoxy-3-pyrimidin-2-ylphenyl)methyl]morpholin-4-yl]-[2-(triazol-2-yl)phenyl]methanone Chemical compound C([C@H]1CC2=CC=C(C(=C2)C=2N=CC=CN=2)OC)OCCN1C(=O)C1=CC=CC=C1N1N=CC=N1 OREIPZHDUFKPTP-LJQANCHMSA-N 0.000 claims 1
- PNGWMHMVJINNEB-LJQANCHMSA-N [(3r)-3-[(4-methoxy-3-thiophen-2-ylphenyl)methyl]morpholin-4-yl]-[2-(triazol-2-yl)phenyl]methanone Chemical compound C([C@H]1CC2=CC=C(C(=C2)C=2SC=CC=2)OC)OCCN1C(=O)C1=CC=CC=C1N1N=CC=N1 PNGWMHMVJINNEB-LJQANCHMSA-N 0.000 claims 1
- OQWDRLJUBNCFEY-GOSISDBHSA-N [(3r)-3-[[2-fluoro-5-(1,2,4-oxadiazol-3-yl)phenyl]methyl]morpholin-4-yl]-[3-methyl-2-(triazol-2-yl)phenyl]methanone Chemical compound C([C@@H]1COCCN1C(=O)C=1C=CC=C(C=1N1N=CC=N1)C)C(C(=CC=1)F)=CC=1C=1N=CON=1 OQWDRLJUBNCFEY-GOSISDBHSA-N 0.000 claims 1
- FJYYNLJIKKPGEW-GOSISDBHSA-N [(3r)-3-[[2-fluoro-5-(1,2,4-oxadiazol-3-yl)phenyl]methyl]morpholin-4-yl]-[4-methyl-2-(triazol-2-yl)phenyl]methanone Chemical compound C([C@@H]1COCCN1C(=O)C1=CC=C(C=C1N1N=CC=N1)C)C(C(=CC=1)F)=CC=1C=1N=CON=1 FJYYNLJIKKPGEW-GOSISDBHSA-N 0.000 claims 1
- WVPNFJYCRRGGLI-GOSISDBHSA-N [(3r)-3-[[2-fluoro-5-(1,2,4-oxadiazol-3-yl)phenyl]methyl]morpholin-4-yl]-[5-methyl-2-(triazol-2-yl)phenyl]methanone Chemical compound C([C@@H]1COCCN1C(=O)C=1C(=CC=C(C=1)C)N1N=CC=N1)C(C(=CC=1)F)=CC=1C=1N=CON=1 WVPNFJYCRRGGLI-GOSISDBHSA-N 0.000 claims 1
- HVGUQKUDHLWJBC-GOSISDBHSA-N [(3r)-3-[[2-fluoro-5-(triazol-2-yl)phenyl]methyl]morpholin-4-yl]-[2-(triazol-2-yl)phenyl]methanone Chemical compound C([C@H]1CC2=CC(=CC=C2F)N2N=CC=N2)OCCN1C(=O)C1=CC=CC=C1N1N=CC=N1 HVGUQKUDHLWJBC-GOSISDBHSA-N 0.000 claims 1
- BUUBXHARNCJISZ-GOSISDBHSA-N [(3r)-3-[[2-fluoro-5-(triazol-2-yl)phenyl]methyl]morpholin-4-yl]-[4-methoxy-2-(triazol-2-yl)phenyl]methanone Chemical compound C([C@@H]1COCCN1C(=O)C1=CC=C(C=C1N1N=CC=N1)OC)C(C(=CC=1)F)=CC=1N1N=CC=N1 BUUBXHARNCJISZ-GOSISDBHSA-N 0.000 claims 1
- HWCNAOSLUJKVML-LJQANCHMSA-N [(3r)-3-[[2-fluoro-5-(triazol-2-yl)phenyl]methyl]morpholin-4-yl]-[4-methyl-2-(triazol-2-yl)phenyl]methanone Chemical compound C([C@@H]1COCCN1C(=O)C1=CC=C(C=C1N1N=CC=N1)C)C(C(=CC=1)F)=CC=1N1N=CC=N1 HWCNAOSLUJKVML-LJQANCHMSA-N 0.000 claims 1
- ORPRTCJZBDNPEM-LJQANCHMSA-N [(3r)-3-[[2-fluoro-5-(triazol-2-yl)phenyl]methyl]morpholin-4-yl]-[5-methyl-2-(triazol-2-yl)phenyl]methanone Chemical compound C([C@@H]1COCCN1C(=O)C=1C(=CC=C(C=1)C)N1N=CC=N1)C(C(=CC=1)F)=CC=1N1N=CC=N1 ORPRTCJZBDNPEM-LJQANCHMSA-N 0.000 claims 1
- CXGGFUAERWUYLI-GOSISDBHSA-N [(3r)-3-[[3-(1,2,4-oxadiazol-3-yl)phenyl]methyl]morpholin-4-yl]-[2-(triazol-2-yl)-4-(trifluoromethyl)phenyl]methanone Chemical compound C([C@@H]1COCCN1C(=O)C1=CC=C(C=C1N1N=CC=N1)C(F)(F)F)C(C=1)=CC=CC=1C=1N=CON=1 CXGGFUAERWUYLI-GOSISDBHSA-N 0.000 claims 1
- HVSHPQWTNYULCB-LJQANCHMSA-N [(3r)-3-[[3-(1,3-oxazol-2-yl)phenyl]methyl]morpholin-4-yl]-[2-(triazol-2-yl)phenyl]methanone Chemical compound C([C@@H]1COCCN1C(=O)C=1C(=CC=CC=1)N1N=CC=N1)C(C=1)=CC=CC=1C1=NC=CO1 HVSHPQWTNYULCB-LJQANCHMSA-N 0.000 claims 1
- FYEWZQAALXXWSM-LJQANCHMSA-N [(3r)-3-[[3-(1,3-thiazol-2-yl)phenyl]methyl]morpholin-4-yl]-[2-(triazol-2-yl)phenyl]methanone Chemical compound C([C@@H]1COCCN1C(=O)C=1C(=CC=CC=1)N1N=CC=N1)C(C=1)=CC=CC=1C1=NC=CS1 FYEWZQAALXXWSM-LJQANCHMSA-N 0.000 claims 1
- WXVVKTBDFXUAHG-OAQYLSRUSA-N [(3r)-3-[[3-(4-methylpyrimidin-2-yl)phenyl]methyl]morpholin-4-yl]-[2-(triazol-2-yl)phenyl]methanone Chemical compound CC1=CC=NC(C=2C=C(C[C@H]3N(CCOC3)C(=O)C=3C(=CC=CC=3)N3N=CC=N3)C=CC=2)=N1 WXVVKTBDFXUAHG-OAQYLSRUSA-N 0.000 claims 1
- OYWUQQROZYATHC-JOCHJYFZSA-N [(3r)-3-[[3-(4-methylpyrimidin-2-yl)phenyl]methyl]morpholin-4-yl]-[5-methyl-2-(triazol-2-yl)phenyl]methanone Chemical compound C([C@@H]1COCCN1C(=O)C=1C(=CC=C(C=1)C)N1N=CC=N1)C(C=1)=CC=CC=1C1=NC=CC(C)=N1 OYWUQQROZYATHC-JOCHJYFZSA-N 0.000 claims 1
- APWITTXYMQNNTN-LJQANCHMSA-N [(3r)-3-[[3-(triazol-2-yl)phenyl]methyl]morpholin-4-yl]-[2-(triazol-2-yl)-4-(trifluoromethyl)phenyl]methanone Chemical compound C([C@@H]1COCCN1C(=O)C1=CC=C(C=C1N1N=CC=N1)C(F)(F)F)C(C=1)=CC=CC=1N1N=CC=N1 APWITTXYMQNNTN-LJQANCHMSA-N 0.000 claims 1
- KXYYELXHLGICGL-HXUWFJFHSA-N [(3r)-3-[[3-chloro-5-(triazol-2-yl)phenyl]methyl]morpholin-4-yl]-[3-methyl-2-(triazol-2-yl)phenyl]methanone Chemical compound C([C@@H]1COCCN1C(=O)C=1C=CC=C(C=1N1N=CC=N1)C)C(C=1)=CC(Cl)=CC=1N1N=CC=N1 KXYYELXHLGICGL-HXUWFJFHSA-N 0.000 claims 1
- LHHCFJSPYOKYPR-HXUWFJFHSA-N [(3r)-3-[[3-chloro-5-(triazol-2-yl)phenyl]methyl]morpholin-4-yl]-[4-methyl-2-(triazol-2-yl)phenyl]methanone Chemical compound C([C@@H]1COCCN1C(=O)C1=CC=C(C=C1N1N=CC=N1)C)C(C=1)=CC(Cl)=CC=1N1N=CC=N1 LHHCFJSPYOKYPR-HXUWFJFHSA-N 0.000 claims 1
- BQSVOWNLNGKKOQ-MRXNPFEDSA-N [(3r)-3-[[4-chloro-3-(1,2,4-oxadiazol-3-yl)phenyl]methyl]morpholin-4-yl]-[2-(triazol-2-yl)phenyl]methanone Chemical compound C([C@H]1CC2=CC=C(C(=C2)C2=NOC=N2)Cl)OCCN1C(=O)C1=CC=CC=C1N1N=CC=N1 BQSVOWNLNGKKOQ-MRXNPFEDSA-N 0.000 claims 1
- HUPRZYCCDOZRQO-QGZVFWFLSA-N [(3r)-3-[[4-methoxy-3-(1,2,4-oxadiazol-3-yl)phenyl]methyl]morpholin-4-yl]-[2-(triazol-2-yl)phenyl]methanone Chemical compound C([C@H]1CC2=CC=C(C(=C2)C2=NOC=N2)OC)OCCN1C(=O)C1=CC=CC=C1N1N=CC=N1 HUPRZYCCDOZRQO-QGZVFWFLSA-N 0.000 claims 1
- UWCQHIQVETWOCJ-GOSISDBHSA-N [(3r)-3-[[4-methoxy-3-(1,2,4-oxadiazol-3-yl)phenyl]methyl]morpholin-4-yl]-[2-methyl-6-(triazol-2-yl)phenyl]methanone Chemical compound C([C@H]1CC2=CC=C(C(=C2)C2=NOC=N2)OC)OCCN1C(=O)C1=C(C)C=CC=C1N1N=CC=N1 UWCQHIQVETWOCJ-GOSISDBHSA-N 0.000 claims 1
- SHBXIINOQJVTRR-GOSISDBHSA-N [(3r)-3-[[4-methoxy-3-(1,2,4-oxadiazol-3-yl)phenyl]methyl]morpholin-4-yl]-[4-methyl-2-(triazol-2-yl)phenyl]methanone Chemical compound C([C@H]1CC2=CC=C(C(=C2)C2=NOC=N2)OC)OCCN1C(=O)C1=CC=C(C)C=C1N1N=CC=N1 SHBXIINOQJVTRR-GOSISDBHSA-N 0.000 claims 1
- PNRIERFKCYVVOG-GOSISDBHSA-N [(3r)-3-[[4-methoxy-3-(1,2,4-oxadiazol-3-yl)phenyl]methyl]morpholin-4-yl]-[5-methyl-2-(triazol-2-yl)phenyl]methanone Chemical compound C([C@H]1CC2=CC=C(C(=C2)C2=NOC=N2)OC)OCCN1C(=O)C1=CC(C)=CC=C1N1N=CC=N1 PNRIERFKCYVVOG-GOSISDBHSA-N 0.000 claims 1
- GHEMSERNBZGDLL-GOSISDBHSA-N [(3r)-3-[[4-methoxy-3-(1,3-oxazol-2-yl)phenyl]methyl]morpholin-4-yl]-[2-(triazol-2-yl)phenyl]methanone Chemical compound C([C@H]1CC2=CC=C(C(=C2)C=2OC=CN=2)OC)OCCN1C(=O)C1=CC=CC=C1N1N=CC=N1 GHEMSERNBZGDLL-GOSISDBHSA-N 0.000 claims 1
- CMSWWEXLVMHQNL-GOSISDBHSA-N [(3r)-3-[[4-methoxy-3-(1,3-thiazol-2-yl)phenyl]methyl]morpholin-4-yl]-[2-(triazol-2-yl)phenyl]methanone Chemical compound C([C@H]1CC2=CC=C(C(=C2)C=2SC=CN=2)OC)OCCN1C(=O)C1=CC=CC=C1N1N=CC=N1 CMSWWEXLVMHQNL-GOSISDBHSA-N 0.000 claims 1
- RFRBKJBYJXZXKQ-LJQANCHMSA-N [(3r)-3-[[4-methyl-3-(1,3-thiazol-2-yl)phenyl]methyl]morpholin-4-yl]-[2-(triazol-2-yl)phenyl]methanone Chemical compound C([C@H]1CC2=CC=C(C(=C2)C=2SC=CN=2)C)OCCN1C(=O)C1=CC=CC=C1N1N=CC=N1 RFRBKJBYJXZXKQ-LJQANCHMSA-N 0.000 claims 1
- XLQIWSDYHVBNIH-LJQANCHMSA-N [(3r)-3-[[4-methyl-3-(triazol-2-yl)phenyl]methyl]morpholin-4-yl]-[2-(triazol-2-yl)phenyl]methanone Chemical compound C([C@H]1CC2=CC=C(C(=C2)N2N=CC=N2)C)OCCN1C(=O)C1=CC=CC=C1N1N=CC=N1 XLQIWSDYHVBNIH-LJQANCHMSA-N 0.000 claims 1
- MLWGTDLBQDBZDR-YLJYHZDGSA-N [(3r,5r)-3-methyl-5-[[3-(triazol-2-yl)phenyl]methyl]morpholin-4-yl]-[2-(triazol-2-yl)phenyl]methanone Chemical compound C([C@@H]1COC[C@H](N1C(=O)C=1C(=CC=CC=1)N1N=CC=N1)C)C(C=1)=CC=CC=1N1N=CC=N1 MLWGTDLBQDBZDR-YLJYHZDGSA-N 0.000 claims 1
- AHOIUZFUVOTFMM-QGZVFWFLSA-N [2-fluoro-3-methoxy-6-(triazol-2-yl)phenyl]-[(3r)-3-[[2-fluoro-5-(triazol-2-yl)phenyl]methyl]morpholin-4-yl]methanone Chemical compound C([C@@H]1COCCN1C(=O)C=1C(=CC=C(C=1F)OC)N1N=CC=N1)C(C(=CC=1)F)=CC=1N1N=CC=N1 AHOIUZFUVOTFMM-QGZVFWFLSA-N 0.000 claims 1
- VVTLUCANNQJJLA-GOSISDBHSA-N [2-fluoro-3-methoxy-6-(triazol-2-yl)phenyl]-[(3r)-3-[[3-(triazol-2-yl)phenyl]methyl]morpholin-4-yl]methanone Chemical compound C([C@@H]1COCCN1C(=O)C=1C(=CC=C(C=1F)OC)N1N=CC=N1)C(C=1)=CC=CC=1N1N=CC=N1 VVTLUCANNQJJLA-GOSISDBHSA-N 0.000 claims 1
- KTJOHPLNNYAVJM-HXUWFJFHSA-N [2-fluoro-3-methyl-6-(triazol-2-yl)phenyl]-[(3r)-3-[(3-pyrazol-1-ylphenyl)methyl]morpholin-4-yl]methanone Chemical compound C([C@@H]1COCCN1C(=O)C=1C(=CC=C(C=1F)C)N1N=CC=N1)C(C=1)=CC=CC=1N1C=CC=N1 KTJOHPLNNYAVJM-HXUWFJFHSA-N 0.000 claims 1
- VPQUBVYYWSMYEA-HXUWFJFHSA-N [2-fluoro-3-methyl-6-(triazol-2-yl)phenyl]-[(3r)-3-[(3-pyrimidin-2-ylphenyl)methyl]morpholin-4-yl]methanone Chemical compound C([C@@H]1COCCN1C(=O)C=1C(=CC=C(C=1F)C)N1N=CC=N1)C(C=1)=CC=CC=1C1=NC=CC=N1 VPQUBVYYWSMYEA-HXUWFJFHSA-N 0.000 claims 1
- STZDRKWMTBHWJI-GOSISDBHSA-N [2-fluoro-3-methyl-6-(triazol-2-yl)phenyl]-[(3r)-3-[[2-fluoro-5-(triazol-2-yl)phenyl]methyl]morpholin-4-yl]methanone Chemical compound C([C@@H]1COCCN1C(=O)C=1C(=CC=C(C=1F)C)N1N=CC=N1)C(C(=CC=1)F)=CC=1N1N=CC=N1 STZDRKWMTBHWJI-GOSISDBHSA-N 0.000 claims 1
- JNZNQAZDCIXPAH-LJQANCHMSA-N [2-fluoro-3-methyl-6-(triazol-2-yl)phenyl]-[(3r)-3-[[3-(triazol-2-yl)phenyl]methyl]morpholin-4-yl]methanone Chemical compound C([C@@H]1COCCN1C(=O)C=1C(=CC=C(C=1F)C)N1N=CC=N1)C(C=1)=CC=CC=1N1N=CC=N1 JNZNQAZDCIXPAH-LJQANCHMSA-N 0.000 claims 1
- LCWVNVDNSNRWAR-QGZVFWFLSA-N [2-fluoro-6-(triazol-2-yl)phenyl]-[(3R)-3-[[2-fluoro-5-(triazol-2-yl)phenyl]methyl]morpholin-4-yl]methanone Chemical compound Fc1ccc(cc1C[C@@H]1COCCN1C(=O)c1c(F)cccc1-n1nccn1)-n1nccn1 LCWVNVDNSNRWAR-QGZVFWFLSA-N 0.000 claims 1
- IEHBRXSPEXUDES-AUSIDOKSSA-N [3,4-dimethyl-2-(triazol-2-yl)phenyl]-[(2r,5r)-2-methyl-5-[(3-pyrimidin-2-ylphenyl)methyl]morpholin-4-yl]methanone Chemical compound C([C@H]1N(C[C@H](OC1)C)C(=O)C=1C(=C(C)C(C)=CC=1)N1N=CC=N1)C(C=1)=CC=CC=1C1=NC=CC=N1 IEHBRXSPEXUDES-AUSIDOKSSA-N 0.000 claims 1
- KZQTUXCCKNLSIX-XMSQKQJNSA-N [3,4-dimethyl-2-(triazol-2-yl)phenyl]-[(2r,5r)-2-methyl-5-[[3-(triazol-2-yl)phenyl]methyl]morpholin-4-yl]methanone Chemical compound C([C@H]1N(C[C@H](OC1)C)C(=O)C=1C(=C(C)C(C)=CC=1)N1N=CC=N1)C(C=1)=CC=CC=1N1N=CC=N1 KZQTUXCCKNLSIX-XMSQKQJNSA-N 0.000 claims 1
- SWDMQWHTMPUUHA-XMSQKQJNSA-N [3,4-dimethyl-2-(triazol-2-yl)phenyl]-[(2r,5r)-5-[(2-fluoro-5-pyrimidin-2-ylphenyl)methyl]-2-methylmorpholin-4-yl]methanone Chemical compound C([C@H]1N(C[C@H](OC1)C)C(=O)C=1C(=C(C)C(C)=CC=1)N1N=CC=N1)C(C(=CC=1)F)=CC=1C1=NC=CC=N1 SWDMQWHTMPUUHA-XMSQKQJNSA-N 0.000 claims 1
- DFLPJQGANRAIIM-OAQYLSRUSA-N [3,4-dimethyl-2-(triazol-2-yl)phenyl]-[(3r)-3-[(2-fluoro-5-pyrimidin-2-ylphenyl)methyl]morpholin-4-yl]methanone Chemical compound C([C@@H]1COCCN1C(=O)C1=CC=C(C(=C1N1N=CC=N1)C)C)C(C(=CC=1)F)=CC=1C1=NC=CC=N1 DFLPJQGANRAIIM-OAQYLSRUSA-N 0.000 claims 1
- DADWYMXJDHTELJ-LJQANCHMSA-N [3,4-dimethyl-2-(triazol-2-yl)phenyl]-[(3r)-3-[[2-fluoro-5-(1,2,4-oxadiazol-3-yl)phenyl]methyl]morpholin-4-yl]methanone Chemical compound C([C@@H]1COCCN1C(=O)C1=CC=C(C(=C1N1N=CC=N1)C)C)C(C(=CC=1)F)=CC=1C=1N=CON=1 DADWYMXJDHTELJ-LJQANCHMSA-N 0.000 claims 1
- XOKDIMBLNFVNEH-HXUWFJFHSA-N [3,4-dimethyl-2-(triazol-2-yl)phenyl]-[(3r)-3-[[2-fluoro-5-(triazol-2-yl)phenyl]methyl]morpholin-4-yl]methanone Chemical compound C([C@@H]1COCCN1C(=O)C1=CC=C(C(=C1N1N=CC=N1)C)C)C(C(=CC=1)F)=CC=1N1N=CC=N1 XOKDIMBLNFVNEH-HXUWFJFHSA-N 0.000 claims 1
- QEFAZNLAURABKO-OAQYLSRUSA-N [3,4-dimethyl-2-(triazol-2-yl)phenyl]-[(3r)-3-[[3-(triazol-2-yl)phenyl]methyl]morpholin-4-yl]methanone Chemical compound C([C@@H]1COCCN1C(=O)C1=CC=C(C(=C1N1N=CC=N1)C)C)C(C=1)=CC=CC=1N1N=CC=N1 QEFAZNLAURABKO-OAQYLSRUSA-N 0.000 claims 1
- WBUINJWSFUWINW-HXUWFJFHSA-N [3,5-dimethyl-2-(triazol-2-yl)phenyl]-[(3r)-3-[[3-(1,2,4-oxadiazol-3-yl)phenyl]methyl]morpholin-4-yl]methanone Chemical compound C([C@@H]1COCCN1C(=O)C=1C(=C(C)C=C(C=1)C)N1N=CC=N1)C(C=1)=CC=CC=1C=1N=CON=1 WBUINJWSFUWINW-HXUWFJFHSA-N 0.000 claims 1
- PYRHLDRQRCTVES-OAQYLSRUSA-N [3,5-dimethyl-2-(triazol-2-yl)phenyl]-[(3r)-3-[[3-(triazol-2-yl)phenyl]methyl]morpholin-4-yl]methanone Chemical compound C([C@@H]1COCCN1C(=O)C=1C(=C(C)C=C(C=1)C)N1N=CC=N1)C(C=1)=CC=CC=1N1N=CC=N1 PYRHLDRQRCTVES-OAQYLSRUSA-N 0.000 claims 1
- CJILJTGWIHZLDC-CRAIPNDOSA-N [3-chloro-2-(triazol-2-yl)phenyl]-[(2R,5R)-5-[[2-fluoro-5-(triazol-2-yl)phenyl]methyl]-2-methylmorpholin-4-yl]methanone Chemical compound ClC=1C(=C(C=CC1)C(=O)N1C[C@H](OC[C@H]1CC1=C(C=CC(=C1)N1N=CC=N1)F)C)N1N=CC=N1 CJILJTGWIHZLDC-CRAIPNDOSA-N 0.000 claims 1
- DUUOWDLWEJVCSI-VQIMIIECSA-N [3-chloro-2-(triazol-2-yl)phenyl]-[(2r,5r)-2-methyl-5-[[3-(triazol-2-yl)phenyl]methyl]morpholin-4-yl]methanone Chemical compound C([C@H]1N(C[C@H](OC1)C)C(=O)C=1C(=C(Cl)C=CC=1)N1N=CC=N1)C(C=1)=CC=CC=1N1N=CC=N1 DUUOWDLWEJVCSI-VQIMIIECSA-N 0.000 claims 1
- YLJVEPVMPPEJBJ-VQIMIIECSA-N [3-chloro-2-(triazol-2-yl)phenyl]-[(2r,5r)-5-[(2-fluoro-5-pyrimidin-2-ylphenyl)methyl]-2-methylmorpholin-4-yl]methanone Chemical compound C([C@H]1N(C[C@H](OC1)C)C(=O)C=1C(=C(Cl)C=CC=1)N1N=CC=N1)C(C(=CC=1)F)=CC=1C1=NC=CC=N1 YLJVEPVMPPEJBJ-VQIMIIECSA-N 0.000 claims 1
- YGTXKPMZPUBWGV-QGZVFWFLSA-N [3-chloro-2-(triazol-2-yl)phenyl]-[(3R)-3-[[2-chloro-5-(triazol-2-yl)phenyl]methyl]morpholin-4-yl]methanone Chemical compound Clc1ccc(cc1C[C@@H]1COCCN1C(=O)c1cccc(Cl)c1-n1nccn1)-n1nccn1 YGTXKPMZPUBWGV-QGZVFWFLSA-N 0.000 claims 1
- JHVXWNVBCOMNJH-GOSISDBHSA-N [3-chloro-2-(triazol-2-yl)phenyl]-[(3r)-3-[(2-fluoro-5-pyrimidin-2-ylphenyl)methyl]morpholin-4-yl]methanone Chemical compound C([C@H]1CC2=CC(=CC=C2F)C=2N=CC=CN=2)OCCN1C(=O)C1=CC=CC(Cl)=C1N1N=CC=N1 JHVXWNVBCOMNJH-GOSISDBHSA-N 0.000 claims 1
- CGFVLVBFXFGDNF-MRXNPFEDSA-N [3-chloro-2-(triazol-2-yl)phenyl]-[(3r)-3-[[2-fluoro-5-(1,2,4-oxadiazol-3-yl)phenyl]methyl]morpholin-4-yl]methanone Chemical compound C([C@H]1CC2=CC(=CC=C2F)C2=NOC=N2)OCCN1C(=O)C1=CC=CC(Cl)=C1N1N=CC=N1 CGFVLVBFXFGDNF-MRXNPFEDSA-N 0.000 claims 1
- IVIQQEWOFAIBMX-QGZVFWFLSA-N [3-chloro-2-(triazol-2-yl)phenyl]-[(3r)-3-[[2-fluoro-5-(triazol-2-yl)phenyl]methyl]morpholin-4-yl]methanone Chemical compound C([C@H]1CC2=CC(=CC=C2F)N2N=CC=N2)OCCN1C(=O)C1=CC=CC(Cl)=C1N1N=CC=N1 IVIQQEWOFAIBMX-QGZVFWFLSA-N 0.000 claims 1
- IGNKAYVYFKMOBL-GOSISDBHSA-N [3-chloro-2-(triazol-2-yl)phenyl]-[(3r)-3-[[3-(triazol-2-yl)phenyl]methyl]morpholin-4-yl]methanone Chemical compound C([C@@H]1COCCN1C(=O)C=1C=CC=C(C=1N1N=CC=N1)Cl)C(C=1)=CC=CC=1N1N=CC=N1 IGNKAYVYFKMOBL-GOSISDBHSA-N 0.000 claims 1
- MWFCDHIHHZBJPV-QGZVFWFLSA-N [3-fluoro-2-(triazol-2-yl)phenyl]-[(3r)-3-[[3-(1,2,4-oxadiazol-3-yl)phenyl]methyl]morpholin-4-yl]methanone Chemical compound C([C@@H]1COCCN1C(=O)C=1C=CC=C(C=1N1N=CC=N1)F)C(C=1)=CC=CC=1C=1N=CON=1 MWFCDHIHHZBJPV-QGZVFWFLSA-N 0.000 claims 1
- BQVDTYWMMKIXOA-GOSISDBHSA-N [3-fluoro-2-(triazol-2-yl)phenyl]-[(3r)-3-[[3-(triazol-2-yl)phenyl]methyl]morpholin-4-yl]methanone Chemical compound C([C@@H]1COCCN1C(=O)C=1C=CC=C(C=1N1N=CC=N1)F)C(C=1)=CC=CC=1N1N=CC=N1 BQVDTYWMMKIXOA-GOSISDBHSA-N 0.000 claims 1
- HMJZZKHOLAJQCJ-PGRDOPGGSA-N [3-methyl-2-(triazol-2-yl)phenyl]-[(2S,3R)-2-methyl-3-[[3-(triazol-2-yl)phenyl]methyl]morpholin-4-yl]methanone Chemical compound C[C@H]1[C@H](N(CCO1)C(=O)C1=C(C(=CC=C1)C)N1N=CC=N1)CC1=CC(=CC=C1)N1N=CC=N1 HMJZZKHOLAJQCJ-PGRDOPGGSA-N 0.000 claims 1
- WRLVGTRMEZGZFE-WIYYLYMNSA-N [3-methyl-2-(triazol-2-yl)phenyl]-[(2r,5r)-2-methyl-5-[[3-(triazol-2-yl)phenyl]methyl]morpholin-4-yl]methanone Chemical compound C([C@H]1N(C[C@H](OC1)C)C(=O)C=1C(=C(C)C=CC=1)N1N=CC=N1)C(C=1)=CC=CC=1N1N=CC=N1 WRLVGTRMEZGZFE-WIYYLYMNSA-N 0.000 claims 1
- OQHUOGSZVADTEQ-OAQYLSRUSA-N [3-methyl-2-(triazol-2-yl)phenyl]-[(3R)-3-[[2-methyl-5-(triazol-2-yl)phenyl]methyl]morpholin-4-yl]methanone Chemical compound CC1=C(C[C@H]2N(CCOC2)C(=O)C2=C(C(=CC=C2)C)N2N=CC=N2)C=C(C=C1)N1N=CC=N1 OQHUOGSZVADTEQ-OAQYLSRUSA-N 0.000 claims 1
- UGPJDNRZMHMMDB-LJQANCHMSA-N [3-methyl-2-(triazol-2-yl)phenyl]-[(3r)-3-[[3-(1,2,4-oxadiazol-3-yl)phenyl]methyl]morpholin-4-yl]methanone Chemical compound C([C@@H]1COCCN1C(=O)C=1C=CC=C(C=1N1N=CC=N1)C)C(C=1)=CC=CC=1C=1N=CON=1 UGPJDNRZMHMMDB-LJQANCHMSA-N 0.000 claims 1
- NERGNQKZFUFHEN-HXUWFJFHSA-N [3-methyl-2-(triazol-2-yl)phenyl]-[(3r)-3-[[3-(triazol-2-yl)phenyl]methyl]morpholin-4-yl]methanone Chemical compound C([C@@H]1COCCN1C(=O)C=1C=CC=C(C=1N1N=CC=N1)C)C(C=1)=CC=CC=1N1N=CC=N1 NERGNQKZFUFHEN-HXUWFJFHSA-N 0.000 claims 1
- UFYCDZYJXMCYQI-WIYYLYMNSA-N [3-methyl-2-(triazol-2-yl)phenyl]-[(3r,5r)-3-methyl-5-[[3-(triazol-2-yl)phenyl]methyl]morpholin-4-yl]methanone Chemical compound C([C@@H]1COC[C@H](N1C(=O)C=1C(=C(C)C=CC=1)N1N=CC=N1)C)C(C=1)=CC=CC=1N1N=CC=N1 UFYCDZYJXMCYQI-WIYYLYMNSA-N 0.000 claims 1
- UFYCDZYJXMCYQI-GHTZIAJQSA-N [3-methyl-2-(triazol-2-yl)phenyl]-[(3s,5r)-3-methyl-5-[[3-(triazol-2-yl)phenyl]methyl]morpholin-4-yl]methanone Chemical compound C([C@@H]1COC[C@@H](N1C(=O)C=1C(=C(C)C=CC=1)N1N=CC=N1)C)C(C=1)=CC=CC=1N1N=CC=N1 UFYCDZYJXMCYQI-GHTZIAJQSA-N 0.000 claims 1
- HMSWWKWVPAKARQ-MRXNPFEDSA-N [4,5-difluoro-2-(triazol-2-yl)phenyl]-[(3r)-3-[[2-fluoro-5-(triazol-2-yl)phenyl]methyl]morpholin-4-yl]methanone Chemical compound C([C@@H]1COCCN1C(=O)C=1C=C(C(=CC=1N1N=CC=N1)F)F)C(C(=CC=1)F)=CC=1N1N=CC=N1 HMSWWKWVPAKARQ-MRXNPFEDSA-N 0.000 claims 1
- KOVCCWGOMZVONL-MRXNPFEDSA-N [4,5-difluoro-2-(triazol-2-yl)phenyl]-[(3r)-3-[[3-(1,2,4-oxadiazol-3-yl)phenyl]methyl]morpholin-4-yl]methanone Chemical compound C([C@@H]1COCCN1C(=O)C=1C=C(C(=CC=1N1N=CC=N1)F)F)C(C=1)=CC=CC=1C=1N=CON=1 KOVCCWGOMZVONL-MRXNPFEDSA-N 0.000 claims 1
- DTAVCGIFLPXIFF-QGZVFWFLSA-N [4,5-difluoro-2-(triazol-2-yl)phenyl]-[(3r)-3-[[3-(triazol-2-yl)phenyl]methyl]morpholin-4-yl]methanone Chemical compound C([C@@H]1COCCN1C(=O)C=1C=C(C(=CC=1N1N=CC=N1)F)F)C(C=1)=CC=CC=1N1N=CC=N1 DTAVCGIFLPXIFF-QGZVFWFLSA-N 0.000 claims 1
- HJRBUDPCLJIXSQ-LJQANCHMSA-N [4,5-dimethoxy-2-(triazol-2-yl)phenyl]-[(3r)-3-[[3-(triazol-2-yl)phenyl]methyl]morpholin-4-yl]methanone Chemical compound C([C@@H]1COCCN1C(=O)C=1C=C(C(=CC=1N1N=CC=N1)OC)OC)C(C=1)=CC=CC=1N1N=CC=N1 HJRBUDPCLJIXSQ-LJQANCHMSA-N 0.000 claims 1
- QGLAATQFBFNUCL-DENIHFKCSA-N [4,5-dimethyl-2-(triazol-2-yl)phenyl]-[(2r,5r)-2-methyl-5-[[3-(triazol-2-yl)phenyl]methyl]morpholin-4-yl]methanone Chemical compound C([C@H]1N(C[C@H](OC1)C)C(=O)C=1C(=CC(C)=C(C)C=1)N1N=CC=N1)C(C=1)=CC=CC=1N1N=CC=N1 QGLAATQFBFNUCL-DENIHFKCSA-N 0.000 claims 1
- PUBPGWFEGLTPSV-LJQANCHMSA-N [4,5-dimethyl-2-(triazol-2-yl)phenyl]-[(3r)-3-[[2-fluoro-5-(1,2,4-oxadiazol-3-yl)phenyl]methyl]morpholin-4-yl]methanone Chemical compound C([C@@H]1COCCN1C(=O)C=1C=C(C(=CC=1N1N=CC=N1)C)C)C(C(=CC=1)F)=CC=1C=1N=CON=1 PUBPGWFEGLTPSV-LJQANCHMSA-N 0.000 claims 1
- DPAIDVFQHYLKSX-HXUWFJFHSA-N [4,5-dimethyl-2-(triazol-2-yl)phenyl]-[(3r)-3-[[2-fluoro-5-(triazol-2-yl)phenyl]methyl]morpholin-4-yl]methanone Chemical compound C([C@@H]1COCCN1C(=O)C=1C=C(C(=CC=1N1N=CC=N1)C)C)C(C(=CC=1)F)=CC=1N1N=CC=N1 DPAIDVFQHYLKSX-HXUWFJFHSA-N 0.000 claims 1
- BTNLZELUPKRKLO-HXUWFJFHSA-N [4,5-dimethyl-2-(triazol-2-yl)phenyl]-[(3r)-3-[[3-(1,2,4-oxadiazol-3-yl)phenyl]methyl]morpholin-4-yl]methanone Chemical compound C([C@@H]1COCCN1C(=O)C=1C=C(C(=CC=1N1N=CC=N1)C)C)C(C=1)=CC=CC=1C=1N=CON=1 BTNLZELUPKRKLO-HXUWFJFHSA-N 0.000 claims 1
- WWEKFLWFASRPJA-OAQYLSRUSA-N [4,5-dimethyl-2-(triazol-2-yl)phenyl]-[(3r)-3-[[3-(triazol-2-yl)phenyl]methyl]morpholin-4-yl]methanone Chemical compound C([C@@H]1COCCN1C(=O)C=1C=C(C(=CC=1N1N=CC=N1)C)C)C(C=1)=CC=CC=1N1N=CC=N1 WWEKFLWFASRPJA-OAQYLSRUSA-N 0.000 claims 1
- DLTFUAAXCYAOLA-HXUWFJFHSA-N [4,5-dimethyl-2-(triazol-2-yl)phenyl]-[(3r)-3-[[4-methyl-3-(1,2,4-oxadiazol-3-yl)phenyl]methyl]morpholin-4-yl]methanone Chemical compound C([C@@H]1COCCN1C(=O)C=1C=C(C(=CC=1N1N=CC=N1)C)C)C(C=1)=CC=C(C)C=1C=1N=CON=1 DLTFUAAXCYAOLA-HXUWFJFHSA-N 0.000 claims 1
- QBNJEFPDYRBZMY-SIKLNZKXSA-N [4,5-dimethyl-2-(triazol-2-yl)phenyl]-[(3s,5r)-3-methyl-5-[[3-(triazol-2-yl)phenyl]methyl]morpholin-4-yl]methanone Chemical compound C([C@@H]1COC[C@@H](N1C(=O)C=1C(=CC(C)=C(C)C=1)N1N=CC=N1)C)C(C=1)=CC=CC=1N1N=CC=N1 QBNJEFPDYRBZMY-SIKLNZKXSA-N 0.000 claims 1
- JOAYSRXNJHJJBL-DYESRHJHSA-N [4-chloro-2-(triazol-2-yl)phenyl]-[(2r,5r)-2-methyl-5-[(3-pyrimidin-2-ylphenyl)methyl]morpholin-4-yl]methanone Chemical compound C([C@H]1N(C[C@H](OC1)C)C(=O)C=1C(=CC(Cl)=CC=1)N1N=CC=N1)C(C=1)=CC=CC=1C1=NC=CC=N1 JOAYSRXNJHJJBL-DYESRHJHSA-N 0.000 claims 1
- JTIZTURJDNZRRX-OXQOHEQNSA-N [4-chloro-2-(triazol-2-yl)phenyl]-[(2r,5r)-2-methyl-5-[[3-(triazol-2-yl)phenyl]methyl]morpholin-4-yl]methanone Chemical compound C([C@H]1N(C[C@H](OC1)C)C(=O)C=1C(=CC(Cl)=CC=1)N1N=CC=N1)C(C=1)=CC=CC=1N1N=CC=N1 JTIZTURJDNZRRX-OXQOHEQNSA-N 0.000 claims 1
- UIELPQGRXTWUBL-OXQOHEQNSA-N [4-chloro-2-(triazol-2-yl)phenyl]-[(2r,5r)-5-[(2-fluoro-5-pyrimidin-2-ylphenyl)methyl]-2-methylmorpholin-4-yl]methanone Chemical compound C([C@H]1N(C[C@H](OC1)C)C(=O)C=1C(=CC(Cl)=CC=1)N1N=CC=N1)C(C(=CC=1)F)=CC=1C1=NC=CC=N1 UIELPQGRXTWUBL-OXQOHEQNSA-N 0.000 claims 1
- RYPOYEQLSNWXDC-DNVCBOLYSA-N [4-chloro-2-(triazol-2-yl)phenyl]-[(2r,5r)-5-[[2-fluoro-5-(triazol-2-yl)phenyl]methyl]-2-methylmorpholin-4-yl]methanone Chemical compound C([C@H]1N(C[C@H](OC1)C)C(=O)C=1C(=CC(Cl)=CC=1)N1N=CC=N1)C(C(=CC=1)F)=CC=1N1N=CC=N1 RYPOYEQLSNWXDC-DNVCBOLYSA-N 0.000 claims 1
- AOIUNCRFTKYDNL-GOSISDBHSA-N [4-chloro-2-(triazol-2-yl)phenyl]-[(3R)-3-[[2-chloro-5-(triazol-2-yl)phenyl]methyl]morpholin-4-yl]methanone Chemical compound Clc1ccc(C(=O)N2CCOC[C@H]2Cc2cc(ccc2Cl)-n2nccn2)c(c1)-n1nccn1 AOIUNCRFTKYDNL-GOSISDBHSA-N 0.000 claims 1
- NNBZSPNSBCOMJO-LJQANCHMSA-N [4-chloro-2-(triazol-2-yl)phenyl]-[(3r)-3-[(2-fluoro-5-pyrimidin-2-ylphenyl)methyl]morpholin-4-yl]methanone Chemical compound C([C@H]1CC2=CC(=CC=C2F)C=2N=CC=CN=2)OCCN1C(=O)C1=CC=C(Cl)C=C1N1N=CC=N1 NNBZSPNSBCOMJO-LJQANCHMSA-N 0.000 claims 1
- SBDNJLCIYJRHKZ-QGZVFWFLSA-N [4-chloro-2-(triazol-2-yl)phenyl]-[(3r)-3-[[2-fluoro-5-(1,2,4-oxadiazol-3-yl)phenyl]methyl]morpholin-4-yl]methanone Chemical compound C([C@H]1CC2=CC(=CC=C2F)C2=NOC=N2)OCCN1C(=O)C1=CC=C(Cl)C=C1N1N=CC=N1 SBDNJLCIYJRHKZ-QGZVFWFLSA-N 0.000 claims 1
- IARRCNRCFRHKHB-GOSISDBHSA-N [4-chloro-2-(triazol-2-yl)phenyl]-[(3r)-3-[[2-fluoro-5-(triazol-2-yl)phenyl]methyl]morpholin-4-yl]methanone Chemical compound C([C@H]1CC2=CC(=CC=C2F)N2N=CC=N2)OCCN1C(=O)C1=CC=C(Cl)C=C1N1N=CC=N1 IARRCNRCFRHKHB-GOSISDBHSA-N 0.000 claims 1
- BZOBPULTAMYVQD-HXUWFJFHSA-N [4-chloro-2-(triazol-2-yl)phenyl]-[(3r)-3-[[2-methyl-5-(triazol-2-yl)phenyl]methyl]morpholin-4-yl]methanone Chemical compound C([C@H]1CC2=CC(=CC=C2C)N2N=CC=N2)OCCN1C(=O)C1=CC=C(Cl)C=C1N1N=CC=N1 BZOBPULTAMYVQD-HXUWFJFHSA-N 0.000 claims 1
- IUBQIPSNLRGHJH-GOSISDBHSA-N [4-chloro-2-(triazol-2-yl)phenyl]-[(3r)-3-[[3-(1,2,4-oxadiazol-3-yl)phenyl]methyl]morpholin-4-yl]methanone Chemical compound C([C@@H]1COCCN1C(=O)C1=CC=C(C=C1N1N=CC=N1)Cl)C(C=1)=CC=CC=1C=1N=CON=1 IUBQIPSNLRGHJH-GOSISDBHSA-N 0.000 claims 1
- ONVKTAGSXCPXIK-LJQANCHMSA-N [4-chloro-2-(triazol-2-yl)phenyl]-[(3r)-3-[[3-(triazol-2-yl)phenyl]methyl]morpholin-4-yl]methanone Chemical compound C([C@@H]1COCCN1C(=O)C1=CC=C(C=C1N1N=CC=N1)Cl)C(C=1)=CC=CC=1N1N=CC=N1 ONVKTAGSXCPXIK-LJQANCHMSA-N 0.000 claims 1
- JRGASLNNEVZZRN-QGZVFWFLSA-N [4-chloro-5-methoxy-2-(triazol-2-yl)phenyl]-[(3r)-3-[[2-fluoro-5-(triazol-2-yl)phenyl]methyl]morpholin-4-yl]methanone Chemical compound C([C@@H]1COCCN1C(=O)C=1C=C(C(=CC=1N1N=CC=N1)Cl)OC)C(C(=CC=1)F)=CC=1N1N=CC=N1 JRGASLNNEVZZRN-QGZVFWFLSA-N 0.000 claims 1
- XKKKABNXFDRANJ-GOSISDBHSA-N [4-chloro-5-methoxy-2-(triazol-2-yl)phenyl]-[(3r)-3-[[3-(triazol-2-yl)phenyl]methyl]morpholin-4-yl]methanone Chemical compound C([C@@H]1COCCN1C(=O)C=1C=C(C(=CC=1N1N=CC=N1)Cl)OC)C(C=1)=CC=CC=1N1N=CC=N1 XKKKABNXFDRANJ-GOSISDBHSA-N 0.000 claims 1
- QCNZPQHXWUCBEP-LJQANCHMSA-N [4-fluoro-2-(triazol-2-yl)phenyl]-[(3r)-3-[[3-(triazol-2-yl)phenyl]methyl]morpholin-4-yl]methanone Chemical compound C([C@@H]1COCCN1C(=O)C1=CC=C(C=C1N1N=CC=N1)F)C(C=1)=CC=CC=1N1N=CC=N1 QCNZPQHXWUCBEP-LJQANCHMSA-N 0.000 claims 1
- CZXWCWCRILWJKE-QGZVFWFLSA-N [4-fluoro-2-(triazol-2-yl)phenyl]-[(3r)-3-[[4-methoxy-3-(1,2,4-oxadiazol-3-yl)phenyl]methyl]morpholin-4-yl]methanone Chemical compound C([C@H]1CC2=CC=C(C(=C2)C2=NOC=N2)OC)OCCN1C(=O)C1=CC=C(F)C=C1N1N=CC=N1 CZXWCWCRILWJKE-QGZVFWFLSA-N 0.000 claims 1
- ASCMSCIVNMZFPN-GOSISDBHSA-N [4-fluoro-5-methoxy-2-(triazol-2-yl)phenyl]-[(3r)-3-[[3-(triazol-2-yl)phenyl]methyl]morpholin-4-yl]methanone Chemical compound C([C@@H]1COCCN1C(=O)C=1C=C(C(=CC=1N1N=CC=N1)F)OC)C(C=1)=CC=CC=1N1N=CC=N1 ASCMSCIVNMZFPN-GOSISDBHSA-N 0.000 claims 1
- MRZOKJFVVJMJLC-LJQANCHMSA-N [4-methoxy-2-(triazol-2-yl)phenyl]-[(3r)-3-[[3-(triazol-2-yl)phenyl]methyl]morpholin-4-yl]methanone Chemical compound C([C@@H]1COCCN1C(=O)C1=CC=C(C=C1N1N=CC=N1)OC)C(C=1)=CC=CC=1N1N=CC=N1 MRZOKJFVVJMJLC-LJQANCHMSA-N 0.000 claims 1
- WOQOCTXBEIMJQF-XMSQKQJNSA-N [4-methyl-2-(triazol-2-yl)phenyl]-[(2r,3r)-2-methyl-3-[[3-(triazol-2-yl)phenyl]methyl]morpholin-4-yl]methanone Chemical compound C([C@H]1N(CCO[C@@H]1C)C(=O)C=1C(=CC(C)=CC=1)N1N=CC=N1)C(C=1)=CC=CC=1N1N=CC=N1 WOQOCTXBEIMJQF-XMSQKQJNSA-N 0.000 claims 1
- XDAZJJGYLDZHNW-WIYYLYMNSA-N [4-methyl-2-(triazol-2-yl)phenyl]-[(2r,5r)-2-methyl-5-[[3-(triazol-2-yl)phenyl]methyl]morpholin-4-yl]methanone Chemical compound C([C@H]1N(C[C@H](OC1)C)C(=O)C=1C(=CC(C)=CC=1)N1N=CC=N1)C(C=1)=CC=CC=1N1N=CC=N1 XDAZJJGYLDZHNW-WIYYLYMNSA-N 0.000 claims 1
- WOQOCTXBEIMJQF-PGRDOPGGSA-N [4-methyl-2-(triazol-2-yl)phenyl]-[(2s,3r)-2-methyl-3-[[3-(triazol-2-yl)phenyl]methyl]morpholin-4-yl]methanone Chemical compound C([C@H]1N(CCO[C@H]1C)C(=O)C=1C(=CC(C)=CC=1)N1N=CC=N1)C(C=1)=CC=CC=1N1N=CC=N1 WOQOCTXBEIMJQF-PGRDOPGGSA-N 0.000 claims 1
- XDAZJJGYLDZHNW-GHTZIAJQSA-N [4-methyl-2-(triazol-2-yl)phenyl]-[(2s,5r)-2-methyl-5-[[3-(triazol-2-yl)phenyl]methyl]morpholin-4-yl]methanone Chemical compound C([C@H]1N(C[C@@H](OC1)C)C(=O)C=1C(=CC(C)=CC=1)N1N=CC=N1)C(C=1)=CC=CC=1N1N=CC=N1 XDAZJJGYLDZHNW-GHTZIAJQSA-N 0.000 claims 1
- QRQCKASOXSZLKU-OAQYLSRUSA-N [4-methyl-2-(triazol-2-yl)phenyl]-[(3R)-3-[[2-methyl-5-(triazol-2-yl)phenyl]methyl]morpholin-4-yl]methanone Chemical compound CC1=C(C[C@H]2N(CCOC2)C(=O)C2=C(C=C(C=C2)C)N2N=CC=N2)C=C(C=C1)N1N=CC=N1 QRQCKASOXSZLKU-OAQYLSRUSA-N 0.000 claims 1
- WYFQHYNFGVNXFG-OAQYLSRUSA-N [4-methyl-2-(triazol-2-yl)phenyl]-[(3r)-3-[(3-pyrazol-1-ylphenyl)methyl]morpholin-4-yl]methanone Chemical compound C([C@@H]1COCCN1C(=O)C1=CC=C(C=C1N1N=CC=N1)C)C(C=1)=CC=CC=1N1C=CC=N1 WYFQHYNFGVNXFG-OAQYLSRUSA-N 0.000 claims 1
- DCMSTVVYTKCBDX-LJQANCHMSA-N [4-methyl-2-(triazol-2-yl)phenyl]-[(3r)-3-[[3-(1,2,4-oxadiazol-3-yl)phenyl]methyl]morpholin-4-yl]methanone Chemical compound C([C@@H]1COCCN1C(=O)C1=CC=C(C=C1N1N=CC=N1)C)C(C=1)=CC=CC=1C=1N=CON=1 DCMSTVVYTKCBDX-LJQANCHMSA-N 0.000 claims 1
- GKPHAIOJCHBZCT-HXUWFJFHSA-N [4-methyl-2-(triazol-2-yl)phenyl]-[(3r)-3-[[3-(triazol-2-yl)phenyl]methyl]morpholin-4-yl]methanone Chemical compound C([C@@H]1COCCN1C(=O)C1=CC=C(C=C1N1N=CC=N1)C)C(C=1)=CC=CC=1N1N=CC=N1 GKPHAIOJCHBZCT-HXUWFJFHSA-N 0.000 claims 1
- DSAPJEHSDZGZQP-HXUWFJFHSA-N [4-methyl-2-(triazol-2-yl)phenyl]-[(3r)-3-[[4-methyl-3-(triazol-2-yl)phenyl]methyl]morpholin-4-yl]methanone Chemical compound C([C@@H]1COCCN1C(=O)C1=CC=C(C=C1N1N=CC=N1)C)C(C=1)=CC=C(C)C=1N1N=CC=N1 DSAPJEHSDZGZQP-HXUWFJFHSA-N 0.000 claims 1
- FCVGUKJNRFNLDS-WIYYLYMNSA-N [4-methyl-2-(triazol-2-yl)phenyl]-[(3r,5r)-3-methyl-5-[[3-(triazol-2-yl)phenyl]methyl]morpholin-4-yl]methanone Chemical compound C([C@@H]1COC[C@H](N1C(=O)C=1C(=CC(C)=CC=1)N1N=CC=N1)C)C(C=1)=CC=CC=1N1N=CC=N1 FCVGUKJNRFNLDS-WIYYLYMNSA-N 0.000 claims 1
- FCVGUKJNRFNLDS-GHTZIAJQSA-N [4-methyl-2-(triazol-2-yl)phenyl]-[(3s,5r)-3-methyl-5-[[3-(triazol-2-yl)phenyl]methyl]morpholin-4-yl]methanone Chemical compound C([C@@H]1COC[C@@H](N1C(=O)C=1C(=CC(C)=CC=1)N1N=CC=N1)C)C(C=1)=CC=CC=1N1N=CC=N1 FCVGUKJNRFNLDS-GHTZIAJQSA-N 0.000 claims 1
- KKGJPPRCCVZKMV-DYESRHJHSA-N [5-chloro-2-(triazol-2-yl)phenyl]-[(2r,5r)-2-methyl-5-[(3-pyrimidin-2-ylphenyl)methyl]morpholin-4-yl]methanone Chemical compound C([C@H]1N(C[C@H](OC1)C)C(=O)C=1C(=CC=C(Cl)C=1)N1N=CC=N1)C(C=1)=CC=CC=1C1=NC=CC=N1 KKGJPPRCCVZKMV-DYESRHJHSA-N 0.000 claims 1
- RWWXBFGEFGPVOA-OXQOHEQNSA-N [5-chloro-2-(triazol-2-yl)phenyl]-[(2r,5r)-2-methyl-5-[[3-(triazol-2-yl)phenyl]methyl]morpholin-4-yl]methanone Chemical compound C([C@H]1N(C[C@H](OC1)C)C(=O)C=1C(=CC=C(Cl)C=1)N1N=CC=N1)C(C=1)=CC=CC=1N1N=CC=N1 RWWXBFGEFGPVOA-OXQOHEQNSA-N 0.000 claims 1
- SMVHMTBUOLIQMT-OXQOHEQNSA-N [5-chloro-2-(triazol-2-yl)phenyl]-[(2r,5r)-5-[(2-fluoro-5-pyrimidin-2-ylphenyl)methyl]-2-methylmorpholin-4-yl]methanone Chemical compound C([C@H]1N(C[C@H](OC1)C)C(=O)C=1C(=CC=C(Cl)C=1)N1N=CC=N1)C(C(=CC=1)F)=CC=1C1=NC=CC=N1 SMVHMTBUOLIQMT-OXQOHEQNSA-N 0.000 claims 1
- VZSCFYBYGCGNNT-DNVCBOLYSA-N [5-chloro-2-(triazol-2-yl)phenyl]-[(2r,5r)-5-[[2-fluoro-5-(triazol-2-yl)phenyl]methyl]-2-methylmorpholin-4-yl]methanone Chemical compound C([C@H]1N(C[C@H](OC1)C)C(=O)C=1C(=CC=C(Cl)C=1)N1N=CC=N1)C(C(=CC=1)F)=CC=1N1N=CC=N1 VZSCFYBYGCGNNT-DNVCBOLYSA-N 0.000 claims 1
- LFTFHZCWXHYQAL-LJQANCHMSA-N [5-chloro-2-(triazol-2-yl)phenyl]-[(3r)-3-[(2-fluoro-5-pyrimidin-2-ylphenyl)methyl]morpholin-4-yl]methanone Chemical compound C([C@H]1CC2=CC(=CC=C2F)C=2N=CC=CN=2)OCCN1C(=O)C1=CC(Cl)=CC=C1N1N=CC=N1 LFTFHZCWXHYQAL-LJQANCHMSA-N 0.000 claims 1
- LAINVSFGRYRKDA-HXUWFJFHSA-N [5-chloro-2-(triazol-2-yl)phenyl]-[(3r)-3-[(3-pyrimidin-2-ylphenyl)methyl]morpholin-4-yl]methanone Chemical compound C([C@@H]1COCCN1C(=O)C=1C(=CC=C(C=1)Cl)N1N=CC=N1)C(C=1)=CC=CC=1C1=NC=CC=N1 LAINVSFGRYRKDA-HXUWFJFHSA-N 0.000 claims 1
- GOPNUSXTFNCXKO-QGZVFWFLSA-N [5-chloro-2-(triazol-2-yl)phenyl]-[(3r)-3-[[2-fluoro-5-(1,2,4-oxadiazol-3-yl)phenyl]methyl]morpholin-4-yl]methanone Chemical compound C([C@H]1CC2=CC(=CC=C2F)C2=NOC=N2)OCCN1C(=O)C1=CC(Cl)=CC=C1N1N=CC=N1 GOPNUSXTFNCXKO-QGZVFWFLSA-N 0.000 claims 1
- RWRHTRNNYAAULR-GOSISDBHSA-N [5-chloro-2-(triazol-2-yl)phenyl]-[(3r)-3-[[2-fluoro-5-(triazol-2-yl)phenyl]methyl]morpholin-4-yl]methanone Chemical compound C([C@H]1CC2=CC(=CC=C2F)N2N=CC=N2)OCCN1C(=O)C1=CC(Cl)=CC=C1N1N=CC=N1 RWRHTRNNYAAULR-GOSISDBHSA-N 0.000 claims 1
- IBFHVKISQVPMHU-GOSISDBHSA-N [5-chloro-2-(triazol-2-yl)phenyl]-[(3r)-3-[[3-(1,2,4-oxadiazol-3-yl)phenyl]methyl]morpholin-4-yl]methanone Chemical compound C([C@@H]1COCCN1C(=O)C=1C(=CC=C(C=1)Cl)N1N=CC=N1)C(C=1)=CC=CC=1C=1N=CON=1 IBFHVKISQVPMHU-GOSISDBHSA-N 0.000 claims 1
- CLOOLVHJLDFMDV-LJQANCHMSA-N [5-chloro-2-(triazol-2-yl)phenyl]-[(3r)-3-[[3-(triazol-2-yl)phenyl]methyl]morpholin-4-yl]methanone Chemical compound C([C@@H]1COCCN1C(=O)C=1C(=CC=C(C=1)Cl)N1N=CC=N1)C(C=1)=CC=CC=1N1N=CC=N1 CLOOLVHJLDFMDV-LJQANCHMSA-N 0.000 claims 1
- UMVDIYYEKWWNEU-LJQANCHMSA-N [5-chloro-4-methyl-2-(triazol-2-yl)phenyl]-[(3r)-3-[[3-(triazol-2-yl)phenyl]methyl]morpholin-4-yl]methanone Chemical compound C([C@@H]1COCCN1C(=O)C1=C(C=C(C(=C1)Cl)C)N1N=CC=N1)C(C=1)=CC=CC=1N1N=CC=N1 UMVDIYYEKWWNEU-LJQANCHMSA-N 0.000 claims 1
- SYLDJPVOGVSYAI-HXUWFJFHSA-N [5-fluoro-2-(triazol-2-yl)phenyl]-[(3r)-3-[(3-pyrazol-1-ylphenyl)methyl]morpholin-4-yl]methanone Chemical compound C([C@@H]1COCCN1C(=O)C=1C(=CC=C(C=1)F)N1N=CC=N1)C(C=1)=CC=CC=1N1C=CC=N1 SYLDJPVOGVSYAI-HXUWFJFHSA-N 0.000 claims 1
- TVALGRAHOLPKKR-GOSISDBHSA-N [5-fluoro-2-(triazol-2-yl)phenyl]-[(3r)-3-[[3-(1,2,4-oxadiazol-3-yl)phenyl]methyl]morpholin-4-yl]methanone Chemical compound C([C@@H]1COCCN1C(=O)C=1C(=CC=C(C=1)F)N1N=CC=N1)C(C=1)=CC=CC=1C=1N=CON=1 TVALGRAHOLPKKR-GOSISDBHSA-N 0.000 claims 1
- HGBYUIVSHGPNIW-LJQANCHMSA-N [5-fluoro-2-(triazol-2-yl)phenyl]-[(3r)-3-[[3-(triazol-2-yl)phenyl]methyl]morpholin-4-yl]methanone Chemical compound C([C@@H]1COCCN1C(=O)C=1C(=CC=C(C=1)F)N1N=CC=N1)C(C=1)=CC=CC=1N1N=CC=N1 HGBYUIVSHGPNIW-LJQANCHMSA-N 0.000 claims 1
- GEVLHZAYQOXANJ-HXUWFJFHSA-N [5-methoxy-2-(triazol-2-yl)phenyl]-[(3r)-3-[(3-pyrimidin-2-ylphenyl)methyl]morpholin-4-yl]methanone Chemical compound C([C@@H]1COCCN1C(=O)C=1C(=CC=C(C=1)OC)N1N=CC=N1)C(C=1)=CC=CC=1C1=NC=CC=N1 GEVLHZAYQOXANJ-HXUWFJFHSA-N 0.000 claims 1
- CWBKFZFKBHRMPJ-LJQANCHMSA-N [5-methoxy-2-(triazol-2-yl)phenyl]-[(3r)-3-[[3-(triazol-2-yl)phenyl]methyl]morpholin-4-yl]methanone Chemical compound C([C@@H]1COCCN1C(=O)C=1C(=CC=C(C=1)OC)N1N=CC=N1)C(C=1)=CC=CC=1N1N=CC=N1 CWBKFZFKBHRMPJ-LJQANCHMSA-N 0.000 claims 1
- TXOLBWQUYQXATH-HXUWFJFHSA-N [5-methoxy-4-methyl-2-(triazol-2-yl)phenyl]-[(3r)-3-[[3-(triazol-2-yl)phenyl]methyl]morpholin-4-yl]methanone Chemical compound C([C@@H]1COCCN1C(=O)C=1C=C(C(=CC=1N1N=CC=N1)C)OC)C(C=1)=CC=CC=1N1N=CC=N1 TXOLBWQUYQXATH-HXUWFJFHSA-N 0.000 claims 1
- DZMITGRLYMROFK-WZONZLPQSA-N [5-methyl-2-(triazol-2-yl)phenyl]-[(2r,3r)-2-methyl-3-[[3-(triazol-2-yl)phenyl]methyl]morpholin-4-yl]methanone Chemical compound C([C@H]1N(CCO[C@@H]1C)C(=O)C=1C(=CC=C(C)C=1)N1N=CC=N1)C(C=1)=CC=CC=1N1N=CC=N1 DZMITGRLYMROFK-WZONZLPQSA-N 0.000 claims 1
- DZMITGRLYMROFK-FDDCHVKYSA-N [5-methyl-2-(triazol-2-yl)phenyl]-[(2s,3r)-2-methyl-3-[[3-(triazol-2-yl)phenyl]methyl]morpholin-4-yl]methanone Chemical compound C([C@H]1N(CCO[C@H]1C)C(=O)C=1C(=CC=C(C)C=1)N1N=CC=N1)C(C=1)=CC=CC=1N1N=CC=N1 DZMITGRLYMROFK-FDDCHVKYSA-N 0.000 claims 1
- HQLRZRZXOSRCFC-OAQYLSRUSA-N [5-methyl-2-(triazol-2-yl)phenyl]-[(3R)-3-[[2-methyl-5-(triazol-2-yl)phenyl]methyl]morpholin-4-yl]methanone Chemical compound CC1=C(C[C@H]2N(CCOC2)C(=O)C2=C(C=CC(=C2)C)N2N=CC=N2)C=C(C=C1)N1N=CC=N1 HQLRZRZXOSRCFC-OAQYLSRUSA-N 0.000 claims 1
- AOBDPAOQKBBOMZ-XMMPIXPASA-N [5-methyl-2-(triazol-2-yl)phenyl]-[(3R)-3-methyl-3-[[3-(triazol-2-yl)phenyl]methyl]morpholin-4-yl]methanone Chemical compound C[C@@]1(N(CCOC1)C(=O)C1=C(C=CC(=C1)C)N1N=CC=N1)CC1=CC(=CC=C1)N1N=CC=N1 AOBDPAOQKBBOMZ-XMMPIXPASA-N 0.000 claims 1
- WQKDFCTZXNZINF-OAQYLSRUSA-N [5-methyl-2-(triazol-2-yl)phenyl]-[(3r)-3-[(3-pyrazin-2-ylphenyl)methyl]morpholin-4-yl]methanone Chemical compound C([C@@H]1COCCN1C(=O)C=1C(=CC=C(C=1)C)N1N=CC=N1)C(C=1)=CC=CC=1C1=CN=CC=N1 WQKDFCTZXNZINF-OAQYLSRUSA-N 0.000 claims 1
- GSBLIJRKLPIUPS-OAQYLSRUSA-N [5-methyl-2-(triazol-2-yl)phenyl]-[(3r)-3-[(3-pyrazol-1-ylphenyl)methyl]morpholin-4-yl]methanone Chemical compound C([C@@H]1COCCN1C(=O)C=1C(=CC=C(C=1)C)N1N=CC=N1)C(C=1)=CC=CC=1N1C=CC=N1 GSBLIJRKLPIUPS-OAQYLSRUSA-N 0.000 claims 1
- QZXHCJASGVSEHH-OAQYLSRUSA-N [5-methyl-2-(triazol-2-yl)phenyl]-[(3r)-3-[(3-pyridazin-3-ylphenyl)methyl]morpholin-4-yl]methanone Chemical compound C([C@@H]1COCCN1C(=O)C=1C(=CC=C(C=1)C)N1N=CC=N1)C(C=1)=CC=CC=1C1=CC=CN=N1 QZXHCJASGVSEHH-OAQYLSRUSA-N 0.000 claims 1
- QQGJVBSRNSZDOO-JOCHJYFZSA-N [5-methyl-2-(triazol-2-yl)phenyl]-[(3r)-3-[(3-pyridin-2-ylphenyl)methyl]morpholin-4-yl]methanone Chemical compound C([C@@H]1COCCN1C(=O)C=1C(=CC=C(C=1)C)N1N=CC=N1)C(C=1)=CC=CC=1C1=CC=CC=N1 QQGJVBSRNSZDOO-JOCHJYFZSA-N 0.000 claims 1
- SBTZFUJQUNEVMJ-HSZRJFAPSA-N [5-methyl-2-(triazol-2-yl)phenyl]-[(3r)-3-[(3-pyridin-3-ylphenyl)methyl]morpholin-4-yl]methanone Chemical compound C([C@@H]1COCCN1C(=O)C=1C(=CC=C(C=1)C)N1N=CC=N1)C(C=1)=CC=CC=1C1=CC=CN=C1 SBTZFUJQUNEVMJ-HSZRJFAPSA-N 0.000 claims 1
- KQPLEQHOKPZPHW-HSZRJFAPSA-N [5-methyl-2-(triazol-2-yl)phenyl]-[(3r)-3-[(3-pyridin-4-ylphenyl)methyl]morpholin-4-yl]methanone Chemical compound C([C@@H]1COCCN1C(=O)C=1C(=CC=C(C=1)C)N1N=CC=N1)C(C=1)=CC=CC=1C1=CC=NC=C1 KQPLEQHOKPZPHW-HSZRJFAPSA-N 0.000 claims 1
- JHOLYWCJSQKKLV-OAQYLSRUSA-N [5-methyl-2-(triazol-2-yl)phenyl]-[(3r)-3-[(3-pyrimidin-2-ylphenyl)methyl]morpholin-4-yl]methanone Chemical compound C([C@@H]1COCCN1C(=O)C=1C(=CC=C(C=1)C)N1N=CC=N1)C(C=1)=CC=CC=1C1=NC=CC=N1 JHOLYWCJSQKKLV-OAQYLSRUSA-N 0.000 claims 1
- HBIJQRRDMMOOSE-JOCHJYFZSA-N [5-methyl-2-(triazol-2-yl)phenyl]-[(3r)-3-[(3-pyrrol-1-ylphenyl)methyl]morpholin-4-yl]methanone Chemical compound C([C@@H]1COCCN1C(=O)C=1C(=CC=C(C=1)C)N1N=CC=N1)C(C=1)=CC=CC=1N1C=CC=C1 HBIJQRRDMMOOSE-JOCHJYFZSA-N 0.000 claims 1
- SPVLNBKCMBRTPX-OAQYLSRUSA-N [5-methyl-2-(triazol-2-yl)phenyl]-[(3r)-3-[(3-thiophen-2-ylphenyl)methyl]morpholin-4-yl]methanone Chemical compound C([C@@H]1COCCN1C(=O)C=1C(=CC=C(C=1)C)N1N=CC=N1)C(C=1)=CC=CC=1C1=CC=CS1 SPVLNBKCMBRTPX-OAQYLSRUSA-N 0.000 claims 1
- LZAJTUGFVUQFAB-LJQANCHMSA-N [5-methyl-2-(triazol-2-yl)phenyl]-[(3r)-3-[[3-(1,2,4-oxadiazol-3-yl)phenyl]methyl]morpholin-4-yl]methanone Chemical compound C([C@@H]1COCCN1C(=O)C=1C(=CC=C(C=1)C)N1N=CC=N1)C(C=1)=CC=CC=1C=1N=CON=1 LZAJTUGFVUQFAB-LJQANCHMSA-N 0.000 claims 1
- PUZJVVRRRYQHLK-HXUWFJFHSA-N [5-methyl-2-(triazol-2-yl)phenyl]-[(3r)-3-[[3-(1,2,4-triazol-1-yl)phenyl]methyl]morpholin-4-yl]methanone Chemical compound C([C@@H]1COCCN1C(=O)C=1C(=CC=C(C=1)C)N1N=CC=N1)C(C=1)=CC=CC=1N1C=NC=N1 PUZJVVRRRYQHLK-HXUWFJFHSA-N 0.000 claims 1
- ZGEVFIAJYRECKD-HXUWFJFHSA-N [5-methyl-2-(triazol-2-yl)phenyl]-[(3r)-3-[[3-(1,3-thiazol-2-yl)phenyl]methyl]morpholin-4-yl]methanone Chemical compound C([C@@H]1COCCN1C(=O)C=1C(=CC=C(C=1)C)N1N=CC=N1)C(C=1)=CC=CC=1C1=NC=CS1 ZGEVFIAJYRECKD-HXUWFJFHSA-N 0.000 claims 1
- ZFYSWSAVTSDYNI-HXUWFJFHSA-N [5-methyl-2-(triazol-2-yl)phenyl]-[(3r)-3-[[3-(triazol-1-yl)phenyl]methyl]morpholin-4-yl]methanone Chemical compound C([C@@H]1COCCN1C(=O)C=1C(=CC=C(C=1)C)N1N=CC=N1)C(C=1)=CC=CC=1N1C=CN=N1 ZFYSWSAVTSDYNI-HXUWFJFHSA-N 0.000 claims 1
- JQRRTXWUYXPFEP-HXUWFJFHSA-N [5-methyl-2-(triazol-2-yl)phenyl]-[(3r)-3-[[3-(triazol-2-yl)phenyl]methyl]morpholin-4-yl]methanone Chemical compound C([C@@H]1COCCN1C(=O)C=1C(=CC=C(C=1)C)N1N=CC=N1)C(C=1)=CC=CC=1N1N=CC=N1 JQRRTXWUYXPFEP-HXUWFJFHSA-N 0.000 claims 1
- GZYDOWPTMSDVRI-HXUWFJFHSA-N [5-methyl-2-(triazol-2-yl)phenyl]-[(3r)-3-[[4-methyl-3-(triazol-2-yl)phenyl]methyl]morpholin-4-yl]methanone Chemical compound C([C@@H]1COCCN1C(=O)C=1C(=CC=C(C=1)C)N1N=CC=N1)C(C=1)=CC=C(C)C=1N1N=CC=N1 GZYDOWPTMSDVRI-HXUWFJFHSA-N 0.000 claims 1
- ARAHFWCCUIXFBE-GHTZIAJQSA-N [5-methyl-2-(triazol-2-yl)phenyl]-[(3s,5r)-3-methyl-5-[[3-(triazol-2-yl)phenyl]methyl]morpholin-4-yl]methanone Chemical compound C([C@@H]1COC[C@@H](N1C(=O)C=1C(=CC=C(C)C=1)N1N=CC=N1)C)C(C=1)=CC=CC=1N1N=CC=N1 ARAHFWCCUIXFBE-GHTZIAJQSA-N 0.000 claims 1
- FUOSTXPWTMZICG-LJQANCHMSA-N [6-methyl-3-(triazol-2-yl)pyridin-2-yl]-[(3R)-3-[[3-(triazol-2-yl)phenyl]methyl]morpholin-4-yl]methanone Chemical compound CC1=CC=C(C(=N1)C(=O)N1[C@@H](COCC1)CC1=CC(=CC=C1)N1N=CC=N1)N1N=CC=N1 FUOSTXPWTMZICG-LJQANCHMSA-N 0.000 claims 1
- ZITMXEDGKUYCKA-HXUWFJFHSA-N [6-methyl-3-(triazol-2-yl)pyridin-2-yl]-[(3r)-3-[(3-pyrazol-1-ylphenyl)methyl]morpholin-4-yl]methanone Chemical compound C([C@@H]1COCCN1C(=O)C=1C(=CC=C(N=1)C)N1N=CC=N1)C(C=1)=CC=CC=1N1C=CC=N1 ZITMXEDGKUYCKA-HXUWFJFHSA-N 0.000 claims 1
- 239000013543 active substance Substances 0.000 claims 1
- 239000012752 auxiliary agent Substances 0.000 claims 1
- 229910052799 carbon Inorganic materials 0.000 claims 1
- 125000004432 carbon atom Chemical group C* 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 1
- 125000004428 fluoroalkoxy group Chemical group 0.000 claims 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 125000004353 pyrazol-1-yl group Chemical group [H]C1=NN(*)C([H])=C1[H] 0.000 claims 1
- 125000000246 pyrimidin-2-yl group Chemical group [H]C1=NC(*)=NC([H])=C1[H] 0.000 claims 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Psychiatry (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Addiction (AREA)
- Child & Adolescent Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Claims (16)
1. Spoj, naznačen time, da ima formulu (I)
[image]
formula (I)
u kojoj
Ar1 predstavlja 5-člani ili 6-člani heteroaril odabran iz skupine koju čine: pirolil, pirazolil, triazolil, oksazolil, tiazolil, oksadiazolil, tiofenil, piridinil, pirimidinil, pirazinil, i piridazinil; gdje je navedeni heteroaril nesupstituiran, mono-, ili di-supstituiran, dok su supstituenti neovisno odabrani iz skupine koju čine: (C14)alkil, (C14)alkoksi, halogen, cijano, (C13)fluoroalkil, i (C13)fluoroalkoksi;
R1 predstavlja jedan opcijski supstituent odabran od sljedećih: (C14)alkil, (C14)alkoksi, hidroksi, i halogen;
R2 predstavlja vodik, (C14)alkil, (C14)alkoksi, halogen, ili cijano;
R3 predstavlja vodik, (C14)alkil, (C14)alkoksi, (C13)fluoroalkil, ili halogen;
R4 predstavlja vodik, (C14)alkil, (C13)fluoroalkil, ili halogen;
R5 predstavlja jedan opcijski supstituent na bilo kojem prstenovom atomu ugljika od morfolin-prstena, gdje je navedeni supstituent neovisno metil ili etil; i
Q predstavlja CR6; ili, u slučaju kada R2 je (C14)alkil ili (C14)alkoksi, tada Q predstavlja CR6 ili N; pri čemu
R6 predstavlja vodik, fluoro ili metil;
ili njegova farmaceutski prihvatljiva sol.
2. Spoj prema zahtjevu 1, naznačen time, da je
morfolin-prsten od spoja formule (I):
[image]
,
takav prsten koji je odabran iz skupine koja se sastoji od sljedećih:
[image]
,
[image]
,
[image]
,
[image]
,
[image]
, i
[image]
;
Ar1 predstavlja 5-člani ili 6-člani heteroaril odabran iz skupine koju čine: pirolil, pirazolil, triazolil, oksazolil, tiazolil, oksadiazolil, tiofenil, piridinil, pirimidinil, pirazinil, i piridazinil; dok je navedeni heteroaril nesupstituiran ili mono-supstituiran sa (C14)alkilom;
R1 predstavlja jedan opcijski supstituent odabran od sljedećih: metil, metoksi, hidroksi, i halogen;
R2 predstavlja vodik, metil, metoksi, halogen, ili cijano;
R3 predstavlja vodik, metil, metoksi, trifluoroalkil, ili halogen;
R4 predstavlja vodik, metil, trifluoroalkil, ili halogen;
Q predstavlja CR6; ili, u slučaju kada R2 je metil, tada Q predstavlja CR6 ili N; pri čemu
R6 predstavlja vodik, fluoro ili metil;
ili njegova farmaceutski prihvatljiva sol.
3. Spoj prema zahtjevima 1 ili 2, naznačen time, da Ar1 predstavlja pirazol-1-il, [1,2,3]triazol-2-il, [1,2,4]oksadiazol-3-il, ili pirimidin-2-il, gdje su te skupine nesupstituirane, ili u slučaju skupine pirimidin-2-il, ona je opcijski mono-supstituirana s metilom;
ili njegova farmaceutski prihvatljiva sol.
4. Spoj prema bilo kojem od zahtjeva 1 do 3, naznačen time, da R2 predstavlja vodik, metil, metoksi, cijano, fluoro, ili kloro; R3 predstavlja vodik, metil, trifluorometil, fluoro, ili kloro; R4 predstavlja vodik, metil, trifluorometil, ili fluoro; i Q predstavlja CR6; ili, u slučaju kada R2 je metil, tada Q predstavlja CR6 ili N; pri čemu R6 predstavlja vodik, fluoro ili metil; ili njegova farmaceutski prihvatljiva sol.
5. Spoj prema bilo kojem od zahtjeva 1 do 4, naznačen time, da Q predstavlja CH; ili njegova farmaceutski prihvatljiva sol.
6. Spoj prema bilo kojem od zahtjeva 1 do 3, naznačen time, da R2 predstavlja vodik ili kloro; R3 predstavlja vodik, kloro, metil, ili trifluorometil, R4 predstavlja vodik ili metil; i Q predstavlja CH; ili njegova farmaceutski prihvatljiva sol.
7. Spoj prema bilo kojem od zahtjeva 1 do 3, naznačen time, da je skupina
[image]
,
takva skupina koja je neovisno odabrana od sljedećih skupina A) do F):
A)
[image]
;
B)
[image]
;
C)
[image]
;
D)
[image]
;
E)
[image]
;
F)
[image]
;
ili njegova farmaceutski prihvatljiva sol.
8. Spoj prema bilo kojem od zahtjeva 1 do 3, naznačen time, da je skupina
[image]
,
takva skupina koja je odabrana iz skupine koja se sastoji od sljedećih skupina A) i B):
A)
[image]
;
B)
[image]
;
ili njegova farmaceutski prihvatljiva sol.
9. Spoj prema bilo kojem od zahtjeva 1, 2, ili 4 do 8, naznačen time, da je skupina
[image]
,
takva skupina koja je neovisno odabrana od sljedećih skupina A) to H):
A)
[image]
;
B)
[image]
;
C)
[image]
;
D)
[image]
;
E)
[image]
;
F)
[image]
;
G)
[image]
;
H)
[image]
;
ili njegova farmaceutski prihvatljiva sol.
10. Spoj prema bilo kojem od zahtjeva 1, 2, ili 4 do 8, naznačen time, da je skupina
[image]
,
takva skupina koja je odabrana iz skupine koja se sastoji od sljedećih skupina A) i B):
A)
[image]
; i
B)
[image]
;
ili njegova farmaceutski prihvatljiva sol.
11. Spoj prema zahtjevu 1, naznačen time, da je odabran iz skupine koju čine:
[(R)-3-(3-[1,2,4]oksadiazol-3-il-benzil)-morfolin-4-il]-(2-[1,2,3]triazol-2-il-fenil)-metanon;
(5-metil-2-[1,2,3]triazol-2-il-fenil)-[(R)-3-(3-[1,2,4]oksadiazol-3-il-benzil)-morfolin-4-il]-metanon;
[(R)-3-(4-metoksi-3-piridin-2-il-benzil)-morfolin-4-il]-(2-[1,2,3]triazol-2-il-fenil)-metanon;
[(R)-3-(4-metoksi-3-piridin-3-il-benzil)-morfolin-4-il]-(2-[1,2,3]triazol-2-il-fenil)-metanon;
[(R)-3-(4-metoksi-3-pirimidin-2-il-benzil)-morfolin-4-il]-(2-[1,2,3]triazol-2-il-fenil)-metanon;
[(R)-3-(4-metoksi-3-pirazin-2-il-benzil)-morfolin-4-il]-(2-[1,2,3]triazol-2-il-fenil)-metanon;
[(R)-3-(4-metoksi-3-piridazin-3-il-benzil)-morfolin-4-il]-(2-[1,2,3]triazol-2-il-fenil)-metanon;
[(R)-3-(4-metoksi-3-tiazol-2-il-benzil)-morfolin-4-il]-(2-[1,2,3]triazol-2-il-fenil)-metanon;
[(R)-3-(4-metoksi-3-oksazol-2-il-benzil)-morfolin-4-il]-(2-[1,2,3]triazol-2-il-fenil)-metanon;
[(R)-3-(4-metoksi-3-tiofen-2-il-benzil)-morfolin-4-il]-(2-[1,2,3]triazol-2-il-fenil)-metanon;
(5-metil-2-[1,2,3]triazol-2-il-fenil)-[(R)-3-(3-[1,2,3]triazol-2-il-benzil)-morfolin-4-il]-metanon;
[(R)-3-(3-[1,2,3]triazol-2-il-benzil)-morfolin-4-il]-(2-[1,2,3]triazol-2-il-fenil)-metanon;
[(S)-3-(3-[1,2,3]triazol-2-il-benzil)-morfolin-4-il]-(2-[1,2,3]triazol-2-il-fenil)-metanon;
[(R)-3-(4-metoksi-3-pirazol-1-il-benzil)-morfolin-4-il]-(2-[1,2,3]triazol-2-il-fenil)-metanon;
(5-metil-2-[1,2,3]triazol-2-il-fenil)-[(R)-3-(3-[1,2,3]triazol-1-il-benzil)-morfolin-4-il]-metanon;
[(R)-3-(3-pirazol-1-il-benzil)-morfolin-4-il]-(2-[1,2,3]triazol-2-il-fenil)-metanon;
(5-metil-2-[1,2,3]triazol-2-il-fenil)-[(R)-3-(3-pirimidin-2-il-benzil)-morfolin-4-il]-metanon;
[(R)-3-(3-pirimidin-2-il-benzil)-morfolin-4-il]-(2-[1,2,3]triazol-2-il-fenil)-metanon;
(5-metil-2-[1,2,3]triazol-2-il-fenil)-[(R)-3-(3-pirazol-1-il-benzil)-morfolin-4-il]-metanon;
(5-fluoro-2-[1,2,3]triazol-2-il-fenil)-[(R)-3-(3-pirazol-1-il-benzil)-morfolin-4-il]-metanon;
(2-fluoro-3-metil-6-[1,2,3]triazol-2-il-fenil)-[(R)-3-(3-pirazol-1-il-benzil)-morfolin-4-il]-metanon;
(4-metil-2-[1,2,3]triazol-2-il-fenil)-[(R)-3-(3-pirazol-1-il-benzil)-morfolin-4-il]-metanon;
(5-metil-2-[1,2,3]triazol-2-il-fenil)-[(R)-3-(3-[1,2,4]triazol-1-il-benzil)-morfolin-4-il]-metanon;
(5-metil-2-[1,2,3]triazol-2-il-fenil)-[(R)-3-(3-piridin-2-il-benzil)-morfolin-4-il]-metanon;
(5-metil-2-[1,2,3]triazol-2-il-fenil)-[(R)-3-(3-piridin-3-il-benzil)-morfolin-4-il]-metanon;
(5-fluoro-2-[1,2,3]triazol-2-il-fenil)-[(R)-3-(3-[1,2,3]triazol-2-il-benzil)-morfolin-4-il]-metanon;
(4-metil-2-[1,2,3]triazol-2-il-fenil)-[(R)-3-(3-[1,2,3]triazol-2-il-benzil)-morfolin-4-il]-metanon;
(5-metil-2-[1,2,3]triazol-2-il-fenil)-[(R)-3-(3-piridin-4-il-benzil)-morfolin-4-il]-metanon;
(2-fluoro-3-metil-6-[1,2,3]triazol-2-il-fenil)-[(R)-3-(3-[1,2,3]triazol-2-il-benzil)-morfolin-4-il]-metanon;
(5-kloro-2-[1,2,3]triazol-2-il-fenil)-[(R)-3-(3-[1,2,3]triazol-2-il-benzil)-morfolin-4-il]-metanon;
4-[1,2,3]triazol-2-il-3-[(R)-3-(3-[1,2,3]triazol-2-il-benzil)-morfoline-4-carbonil]-benzonitril;
(5-metoksi-2-[1,2,3]triazol-2-il-fenil)-[(R)-3-(3-[1,2,3]triazol-2-il-benzil)-morfolin-4-il]-metanon;
(2-fluoro-3-metoksi-6-[1,2,3]triazol-2-il-fenil)-[(R)-3-(3-[1,2,3]triazol-2-il-benzil)-morfolin-4-il]-metanon;
(4,5-dimetoksi-2-[1,2,3]triazol-2-il-fenil)-[(R)-3-(3-[1,2,3]triazol-2-il-benzil)-morfolin-4-il]-metanon;
(4,5-dimetil-2-[1,2,3]triazol-2-il-fenil)-[(R)-3-(3-[1,2,3]triazol-2-il-benzil)-morfolin-4-il]-metanon;
(4-fluoro-2-[1,2,3]triazol-2-il-fenil)-[(R)-3-(3-[1,2,3]triazol-2-il-benzil)-morfolin-4-il]-metanon;
(5-metoksi-4-metil-2-[1,2,3]triazol-2-il-fenil)-[(R)-3-(3-[1,2,3]triazol-2-il-benzil)-morfolin-4-il]-metanon;
(5-metil-2-[1,2,3]triazol-2-il-fenil)-[(R)-3-(3-pirrol-1-il-benzil)-morfolin-4-il]-metanon;
{(R)-3-[3-(4-metil-pirimidin-2-il)-benzil]-morfolin-4-il}-(5-metil-2-[1,2,3]triazol-2-il-fenil)-metanon;
{(R)-3-[3-(4-metil-pirimidin-2-il)-benzil]-morfolin-4-il}-(2-[1,2,3]triazol-2-il-fenil)-metanon;
(5-metil-2-[1,2,3]triazol-2-il-fenil)-[(R)-3-(3-pirazin-2-il-benzil)-morfolin-4-il]-metanon;
[(R)-3-(3-oksazol-2-il-benzil)-morfolin-4-il]-(2-[1,2,3]triazol-2-il-fenil)-metanon;
(5-metil-2-[1,2,3]triazol-2-il-fenil)-[(R)-3-(3-tiazol-2-il-benzil)-morfolin-4-il]-metanon;
[(R)-3-(3-tiazol-2-il-benzil)-morfolin-4-il]-(2-[1,2,3]triazol-2-il-fenil)-metanon;
(5-metil-2-[1,2,3]triazol-2-il-fenil)-[(R)-3-(3-tiofen-2-il-benzil)-morfolin-4-il]-metanon;
[(R)-3-(3-tiofen-2-il-benzil)-morfolin-4-il]-(2-[1,2,3]triazol-2-il-fenil)-metanon;
(5-metil-2-[1,2,3]triazol-2-il-fenil)-[(R)-3-(3-piridazin-3-il-benzil)-morfolin-4-il]-metanon;
[(R)-3-(3-piridazin-3-il-benzil)-morfolin-4-il]-(2-[1,2,3]triazol-2-il-fenil)-metanon;
(2-fluoro-3-metil-6-[1,2,3]triazol-2-il-fenil)-[(R)-3-(3-pirimidin-2-il-benzil)-morfolin-4-il]-metanon;
(5-metoksi-2-[1,2,3]triazol-2-il-fenil)-[(R)-3-(3-pirimidin-2-il-benzil)-morfolin-4-il]-metanon;
(5-kloro-2-[1,2,3]triazol-2-il-fenil)-[(R)-3-(3-pirimidin-2-il-benzil)-morfolin-4-il]-metanon;
(6-metil-3-[1,2,3]triazol-2-il-piridin-2-il)-[(R)-3-(3-pirazol-1-il-benzil)-morfolin-4-il]-metanon;
(6-metil-3-[1,2,3]triazol-2-il-piridin-2-il)-[(R)-3-(3-[1,2,3]triazol-2-il-benzil)-morfolin-4-il]-metanon; i
(3-fluoro-2-[1,2,3]triazol-2-il-fenil)-[(R)-3-(3-[1,2,3]triazol-2-il-benzil)-morfolin-4-il]-metanon;
ili njegova farmaceutski prihvatljiva sol.
12. Spoj prema zahtjevu 1, naznačen time, da je odabran iz skupine koju čine:
[(R)-3-(4-hidroksi-3-pirimidin-2-il-benzil)-morfolin-4-il]-(2-[1,2,3]triazol-2-il-fenil)-metanon;
[(R)-3-(2-fluoro-5-[1,2,3]triazol-2-il-benzil)-morfolin-4-il]-(5-metil-2-[1,2,3]triazol-2-il-fenil)-metanon;
[(R)-3-(2-fluoro-5-[1,2,3]triazol-2-il-benzil)-morfolin-4-il]-(2-[1,2,3]triazol-2-il-fenil)-metanon;
[(R)-3-(4-metoksi-3-[1,2,4]oksadiazol-3-il-benzil)-morfolin-4-il]-(5-metil-2-[1,2,3]triazol-2-il-fenil)-metanon;
[(R)-3-(4-metoksi-3-[1,2,4]oksadiazol-3-il-benzil)-morfolin-4-il]-(2-[1,2,3]triazol-2-il-fenil)-metanon;
[(R)-3-(4-metoksi-3-[1,2,4]oksadiazol-3-il-benzil)-morfolin-4-il]-(4-metil-2-[1,2,3]triazol-2-il-fenil)-metanon;
(4-fluoro-2-[1,2,3]triazol-2-il-fenil)-[(R)-3-(4-metoksi-3-[1,2,4]oksadiazol-3-il-benzil)-morfolin-4-il]-metanon;
[(R)-3-(2-fluoro-5-[1,2,3]triazol-2-il-benzil)-morfolin-4-il]-(4-metil-2-[1,2,3]triazol-2-il-fenil)-metanon;
[(R)-3-(4-metoksi-3-[1,2,4]oksadiazol-3-il-benzil)-morfolin-4-il]-(2-metil-6-[1,2,3]triazol-2-il-fenil)-metanon;
(3-metil-2-[1,2,3]triazol-2-il-fenil)-[(R)-3-(3-[1,2,3]triazol-2-il-benzil)-morfolin-4-il]-metanon;
[(R)-3-(4-metil-3-[1,2,3]triazol-2-il-benzil)-morfolin-4-il]-(5-metil-2-[1,2,3]triazol-2-il-fenil)-metanon;
[(R)-3-(4-metil-3-[1,2,3]triazol-2-il-benzil)-morfolin-4-il]-(2-[1,2,3]triazol-2-il-fenil)-metanon;
[(R)-3-(4-metil-3-[1,2,3]triazol-2-il-benzil)-morfolin-4-il]-(4-metil-2-[1,2,3]triazol-2-il-fenil)-metanon;
[(3R,5R)-3-metil-5-(3-[1,2,3]triazol-2-il-benzil)-morfolin-4-il]-(2-[1,2,3]triazol-2-il-fenil)-metanon;
[(3R,5R)-3-metil-5-(3-[1,2,3]triazol-2-il-benzil)-morfolin-4-il]-(4-metil-2-[1,2,3]triazol-2-il-fenil)-metanon;
[(3R,5R)-3-metil-5-(3-[1,2,3]triazol-2-il-benzil)-morfolin-4-il]-(3-metil-2-[1,2,3]triazol-2-il-fenil)-metanon;
[(3S,5R)-3-metil-5-(3-[1,2,3]triazol-2-il-benzil)-morfolin-4-il]-(4-metil-2-[1,2,3]triazol-2-il-fenil)-metanon;
[(3S,5R)-3-metil-5-(3-[1,2,3]triazol-2-il-benzil)-morfolin-4-il]-(3-metil-2-[1,2,3]triazol-2-il-fenil)-metanon;
[(3S,5R)-3-metil-5-(3-[1,2,3]triazol-2-il-benzil)-morfolin-4-il]-(5-metil-2-[1,2,3]triazol-2-il-fenil)-metanon;
(4,5-dimetil-2-[1,2,3]triazol-2-il-fenil)-[(3S,5R)-3-metil-5-(3-[1,2,3]triazol-2-il-benzil)-morfolin-4-il]-metanon;
(3,5-dimetil-2-[1,2,3]triazol-2-il-fenil)-[(R)-3-(3-[1,2,3]triazol-2-il-benzil)-morfolin-4-il]-metanon;
[(R)-3-(3-[1,2,3]triazol-2-il-benzil)-morfolin-4-il]-(2-[1,2,3]triazol-2-il-4-trifluorometil-fenil)-metanon;
(4-kloro-2-[1,2,3]triazol-2-il-fenil)-[(R)-3-(3-[1,2,3]triazol-2-il-benzil)-morfolin-4-il]-metanon;
(4-fluoro-5-metoksi-2-[1,2,3]triazol-2-il-fenil)-[(R)-3-(3-[1,2,3]triazol-2-il-benzil)-morfolin-4-il]-metanon;
(4,5-dimetil-2-[1,2,3]triazol-2-il-fenil)-[(R)-3-(4-metil-3-[1,2,4]oksadiazol-3-il-benzil)-morfolin-4-il]-metanon;
(4,5-difluoro-2-[1,2,3]triazol-2-il-fenil)-[(R)-3-(3-[1,2,4]oksadiazol-3-il-benzil)-morfolin-4-il]-metanon;
(4-metil-2-[1,2,3]triazol-2-il-fenil)-[(R)-3-(3-[1,2,4]oksadiazol-3-il-benzil)-morfolin-4-il]-metanon;
(3-fluoro-2-[1,2,3]triazol-2-il-fenil)-[(R)-3-(3-[1,2,4]oksadiazol-3-il-benzil)-morfolin-4-il]-metanon;
(3-metil-2-[1,2,3]triazol-2-il-fenil)-[(R)-3-(3-[1,2,4]oksadiazol-3-il-benzil)-morfolin-4-il]-metanon;
(5-kloro-2-[1,2,3]triazol-2-il-fenil)-[(R)-3-(3-[1,2,4]oksadiazol-3-il-benzil)-morfolin-4-il]-metanon;
(4,5-dimetil-2-[1,2,3]triazol-2-il-fenil)-[(R)-3-(3-[1,2,4]oksadiazol-3-il-benzil)-morfolin-4-il]-metanon;
(4-kloro-2-[1,2,3]triazol-2-il-fenil)-[(R)-3-(3-[1,2,4]oksadiazol-3-il-benzil)-morfolin-4-il]-metanon;
[(R)-3-(3-[1,2,4]oksadiazol-3-il-benzil)-morfolin-4-il]-(2-[1,2,3]triazol-2-il-4-trifluorometil-fenil)-metanon;
(5-fluoro-2-[1,2,3]triazol-2-il-fenil)-[(R)-3-(3-[1,2,4]oksadiazol-3-il-benzil)-morfolin-4-il]-metanon;
(3,5-dimetil-2-[1,2,3]triazol-2-il-fenil)-[(R)-3-(3-[1,2,4]oksadiazol-3-il-benzil)-morfolin-4-il]-metanon;
[(R)-3-(4-kloro-3-[1,2,4]oksadiazol-3-il-benzil)-morfolin-4-il]-(2-[1,2,3]triazol-2-il-fenil)-metanon;
(4,5-difluoro-2-[1,2,3]triazol-2-il-fenil)-[(R)-3-(3-[1,2,3]triazol-2-il-benzil)-morfolin-4-il]-metanon;
(3,4-dimetil-2-[1,2,3]triazol-2-il-fenil)-[(R)-3-(3-[1,2,3]triazol-2-il-benzil)-morfolin-4-il]-metanon;
(4-metoksi-2-[1,2,3]triazol-2-il-fenil)-[(R)-3-(3-[1,2,3]triazol-2-il-benzil)-morfolin-4-il]-metanon;
(3,4-dimetil-2-[1,2,3]triazol-2-il-fenil)-[(R)-3-(2-fluoro-5-[1,2,3]triazol-2-il-benzil)-morfolin-4-il]-metanon;
[(R)-3-(2-fluoro-5-[1,2,3]triazol-2-il-benzil)-morfolin-4-il]-(4-metoksi-2-[1,2,3]triazol-2-il-fenil)-metanon;
[(2S,5R)-2-metil-5-(3-[1,2,3]triazol-2-il-benzil)-morfolin-4-il]-(4-metil-2-[1,2,3]triazol-2-il-fenil)-metanon;
[(2R,5R)-2-metil-5-(3-[1,2,3]triazol-2-il-benzil)-morfolin-4-il]-(3-metil-2-[1,2,3]triazol-2-il-fenil)-metanon;
(4,5-dimetil-2-[1,2,3]triazol-2-il-fenil)-[(2R,5R)-2-metil-5-(3-[1,2,3]triazol-2-il-benzil)-morfolin-4-il]-metanon;
(3,4-dimetil-2-[1,2,3]triazol-2-il-fenil)-[(2R,5R)-2-metil-5-(3-[1,2,3]triazol-2-il-benzil)-morfolin-4-il]-metanon;
[(2R,5R)-2-metil-5-(3-[1,2,3]triazol-2-il-benzil)-morfolin-4-il]-(2-[1,2,3]triazol-2-il-fenil)-metanon;
[(2R,5R)-2-metil-5-(3-[1,2,3]triazol-2-il-benzil)-morfolin-4-il]-(4-metil-2-[1,2,3]triazol-2-il-fenil)-metanon;
[(R)-3-metil-3-(3-[1,2,3]triazol-2-il-benzil)-morfolin-4-il]-(5-metil-2-[1,2,3]triazol-2-il-fenil)-metanon;
(5-kloro-4-metil-2-[1,2,3]triazol-2-il-fenil)-[(R)-3-(3-[1,2,3]triazol-2-il-benzil)-morfolin-4-il]-metanon;
(4-kloro-5-metoksi-2-[1,2,3]triazol-2-il-fenil)-[(R)-3-(3-[1,2,3]triazol-2-il-benzil)-morfolin-4-il]-metanon;
[(R)-3-(3-kloro-5-[1,2,3]triazol-2-il-benzil)-morfolin-4-il]-(4-metil-2-[1,2,3]triazol-2-il-fenil)-metanon;
[(R)-3-(3-kloro-5-[1,2,3]triazol-2-il-benzil)-morfolin-4-il]-(3-metil-2-[1,2,3]triazol-2-il-fenil)-metanon;
(3-kloro-2-[1,2,3]triazol-2-il-fenil)-[(R)-3-(3-[1,2,3]triazol-2-il-benzil)-morfolin-4-il]-metanon;
[(2R,5R)-2-metil-5-(3-pirimidin-2-il-benzil)-morfolin-4-il]-(2-[1,2,3]triazol-2-il-fenil)-metanon;
[(2R,5R)-2-metil-5-(3-pirimidin-2-il-benzil)-morfolin-4-il]-(5-metil-2-[1,2,3]triazol-2-il-fenil)-metanon;
[(2R,5R)-2-metil-5-(3-pirimidin-2-il-benzil)-morfolin-4-il]-(4-metil-2-[1,2,3]triazol-2-il-fenil)-metanon;
[(2R,5R)-2-metil-5-(3-pirimidin-2-il-benzil)-morfolin-4-il]-(3-metil-2-[1,2,3]triazol-2-il-fenil)-metanon;
(3,4-dimetil-2-[1,2,3]triazol-2-il-fenil)-[(2R,5R)-2-metil-5-(3-pirimidin-2-il-benzil)-morfolin-4-il]-metanon;
(5-kloro-2-[1,2,3]triazol-2-il-fenil)-[(2R,5R)-2-metil-5-(3-pirimidin-2-il-benzil)-morfolin-4-il]-metanon;
(4-kloro-2-[1,2,3]triazol-2-il-fenil)-[(2R,5R)-2-metil-5-(3-pirimidin-2-il-benzil)-morfolin-4-il]-metanon;
[(2R,5R)-5-(2-fluoro-5-[1,2,3]triazol-2-il-benzil)-2-metil-morfolin-4-il]-(5-metil-2-[1,2,3]triazol-2-il-fenil)-metanon;
[(2R,5R)-5-(2-fluoro-5-[1,2,3]triazol-2-il-benzil)-2-metil-morfolin-4-il]-(2-[1,2,3]triazol-2-il-fenil)-metanon;
[(2R,5R)-5-(2-fluoro-5-[1,2,3]triazol-2-il-benzil)-2-metil-morfolin-4-il]-(4-metil-2-[1,2,3]triazol-2-il-fenil)-metanon;
[(2R,5R)-5-(2-fluoro-5-[1,2,3]triazol-2-il-benzil)-2-metil-morfolin-4-il]-(3-metil-2-[1,2,3]triazol-2-il-fenil)-metanon;
[(R)-3-(2-metil-5-[1,2,3]triazol-2-il-benzil)-morfolin-4-il]-(5-metil-2-[1,2,3]triazol-2-il-fenil)-metanon;
[(R)-3-(2-kloro-5-[1,2,3]triazol-2-il-benzil)-morfolin-4-il]-(4-metil-2-[1,2,3]triazol-2-il-fenil)-metanon;
[(R)-3-(2-metil-5-[1,2,3]triazol-2-il-benzil)-morfolin-4-il]-(2-[1,2,3]triazol-2-il-fenil)-metanon;
[(R)-3-(2-kloro-5-[1,2,3]triazol-2-il-benzil)-morfolin-4-il]-(3-metil-2-[1,2,3]triazol-2-il-fenil)-metanon;
[(R)-3-(2-metil-5-[1,2,3]triazol-2-il-benzil)-morfolin-4-il]-(4-metil-2-[1,2,3]triazol-2-il-fenil)-metanon;
[(R)-3-(2-metil-5-[1,2,3]triazol-2-il-benzil)-morfolin-4-il]-(3-metil-2-[1,2,3]triazol-2-il-fenil)-metanon;
[(R)-3-(2-kloro-5-[1,2,3]triazol-2-il-benzil)-morfolin-4-il]-(5-metil-2-[1,2,3]triazol-2-il-fenil)-metanon;
[(R)-3-(2-kloro-5-[1,2,3]triazol-2-il-benzil)-morfolin-4-il]-(2-[1,2,3]triazol-2-il-fenil)-metanon;
[(R)-3-(2-fluoro-5-[1,2,3]triazol-2-il-benzil)-morfolin-4-il]-(3-metil-2-[1,2,3]triazol-2-il-fenil)-metanon;
(4,5-dimetil-2-[1,2,3]triazol-2-il-fenil)-[(R)-3-(2-fluoro-5-[1,2,3]triazol-2-il-benzil)-morfolin-4-il]-metanon;
(5-kloro-2-[1,2,3]triazol-2-il-fenil)-[(R)-3-(2-fluoro-5-[1,2,3]triazol-2-il-benzil)-morfolin-4-il]-metanon;
(4-kloro-2-[1,2,3]triazol-2-il-fenil)-[(R)-3-(2-fluoro-5-[1,2,3]triazol-2-il-benzil)-morfolin-4-il]-metanon;
[(R)-3-(2-fluoro-5-[1,2,3]triazol-2-il-benzil)-morfolin-4-il]-(5-metoksi-2-[1,2,3]triazol-2-il-fenil)-metanon;
(2-fluoro-3-metil-6-[1,2,3]triazol-2-il-fenil)-[(R)-3-(2-fluoro-5-[1,2,3]triazol-2-il-benzil)-morfolin-4-il]-metanon;
(2-fluoro-3-metoksi-6-[1,2,3]triazol-2-il-fenil)-[(R)-3-(2-fluoro-5-[1,2,3]triazol-2-il-benzil)-morfolin-4-il]-metanon;
[(R)-3-(2-fluoro-5-[1,2,3]triazol-2-il-benzil)-morfolin-4-il]-(5-metoksi-4-metil-2-[1,2,3]triazol-2-il-fenil)-metanon;
(3-kloro-2-[1,2,3]triazol-2-il-fenil)-[(R)-3-(2-fluoro-5-[1,2,3]triazol-2-il-benzil)-morfolin-4-il]-metanon;
[(R)-3-(2-fluoro-5-[1,2,3]triazol-2-il-benzil)-morfolin-4-il]-(2-fluoro-6-[1,2,3]triazol-2-il-fenil)-metanon;
(4,5-difluoro-2-[1,2,3]triazol-2-il-fenil)-[(R)-3-(2-fluoro-5-[1,2,3]triazol-2-il-benzil)-morfolin-4-il]-metanon;
[(R)-3-(2-fluoro-5-[1,2,3]triazol-2-il-benzil)-morfolin-4-il]-(2-[1,2,3]triazol-2-il-4-trifluorometil-fenil)-metanon;
(4-kloro-5-metoksi-2-[1,2,3]triazol-2-il-fenil)-[(R)-3-(2-fluoro-5-[1,2,3]triazol-2-il-benzil)-morfolin-4-il]-metanon;
[(2R,5R)-5-(2-fluoro-5-[1,2,3]triazol-1-il-benzil)-2-metil-morfolin-4-il]-(5-metil-2-[1,2,3]triazol-2-il-fenil)-metanon;
[(2R,5R)-5-(2-fluoro-5-[1,2,3]triazol-1-il-benzil)-2-metil-morfolin-4-il]-(4-metil-2-[1,2,3]triazol-2-il-fenil)-metanon;
[(2R,5R)-2-etil-5-(3-[1,2,3]triazol-2-il-benzil)-morfolin-4-il]-(5-metil-2-[1,2,3]triazol-2-il-fenil)-metanon;
[(2R,5R)-2-etil-5-(3-[1,2,3]triazol-2-il-benzil)-morfolin-4-il]-(2-[1,2,3]triazol-2-il-fenil)-metanon;
[(2R,5R)-2-etil-5-(3-[1,2,3]triazol-2-il-benzil)-morfolin-4-il]-(4-metil-2-[1,2,3]triazol-2-il-fenil)-metanon;
[(R)-3-(3-fluoro-5-[1,2,3]triazol-2-il-benzil)-morfolin-4-il]-(2-[1,2,3]triazol-2-il-fenil)-metanon;
[(R)-3-(3-fluoro-5-[1,2,3]triazol-2-il-benzil)-morfolin-4-il]-(4-metil-2-[1,2,3]triazol-2-il-fenil)-metanon;
[(2R,5R)-5-(2-fluoro-5-pirimidin-2-il-benzil)-2-metil-morfolin-4-il]-(5-metil-2-[1,2,3]triazol-2-il-fenil)-metanon;
[(2R,5R)-5-(2-fluoro-5-pirimidin-2-il-benzil)-2-metil-morfolin-4-il]-(2-[1,2,3]triazol-2-il-fenil)-metanon;
[(2R,5R)-5-(2-fluoro-5-pirimidin-2-il-benzil)-2-metil-morfolin-4-il]-(4-metil-2-[1,2,3]triazol-2-il-fenil)-metanon;
[(2R,5R)-5-(2-fluoro-5-pirimidin-2-il-benzil)-2-metil-morfolin-4-il]-(3-metil-2-[1,2,3]triazol-2-il-fenil)-metanon;
(3,4-dimetil-2-[1,2,3]triazol-2-il-fenil)-[(2R,5R)-5-(2-fluoro-5-pirimidin-2-il-benzil)-2-metil-morfolin-4-il]-metanon;
(5-kloro-2-[1,2,3]triazol-2-il-fenil)-[(2R,5R)-5-(2-fluoro-5-pirimidin-2-il-benzil)-2-metil-morfolin-4-il]-metanon;
(4-kloro-2-[1,2,3]triazol-2-il-fenil)-[(2R,5R)-5-(2-fluoro-5-pirimidin-2-il-benzil)-2-metil-morfolin-4-il]-metanon;
(3-kloro-2-[1,2,3]triazol-2-il-fenil)-[(2R,5R)-5-(2-fluoro-5-pirimidin-2-il-benzil)-2-metil-morfolin-4-il]-metanon;
[(R)-3-(2-fluoro-5-pirimidin-2-il-benzil)-morfolin-4-il]-(5-metil-2-[1,2,3]triazol-2-il-fenil)-metanon;
[(R)-3-(2-fluoro-5-pirimidin-2-il-benzil)-morfolin-4-il]-(4-metil-2-[1,2,3]triazol-2-il-fenil)-metanon;
[(R)-3-(2-fluoro-5-pirimidin-2-il-benzil)-morfolin-4-il]-(3-metil-2-[1,2,3]triazol-2-il-fenil)-metanon;
(3,4-dimetil-2-[1,2,3]triazol-2-il-fenil)-[(R)-3-(2-fluoro-5-pirimidin-2-il-benzil)-morfolin-4-il]-metanon;
(5-kloro-2-[1,2,3]triazol-2-il-fenil)-[(R)-3-(2-fluoro-5-pirimidin-2-il-benzil)-morfolin-4-il]-metanon;
(4-kloro-2-[1,2,3]triazol-2-il-fenil)-[(R)-3-(2-fluoro-5-pirimidin-2-il-benzil)-morfolin-4-il]-metanon;
(3-kloro-2-[1,2,3]triazol-2-il-fenil)-[(R)-3-(2-fluoro-5-pirimidin-2-il-benzil)-morfolin-4-il]-metanon;
[(2S,3R)-2-metil-3-(3-[1,2,3]triazol-2-il-benzil)-morfolin-4-il]-(5-metil-2-[1,2,3]triazol-2-il-fenil)-metanon;
[(2S,3R)-2-metil-3-(3-[1,2,3]triazol-2-il-benzil)-morfolin-4-il]-(4-metil-2-[1,2,3]triazol-2-il-fenil)-metanon;
[(2S,3R)-2-metil-3-(3-[1,2,3]triazol-2-il-benzil)-morfolin-4-il]-(3-metil-2-[1,2,3]triazol-2-il-fenil)-metanon;
[(2R,5R)-5-(2-fluoro-5-piridazin-3-il-benzil)-2-metil-morfolin-4-il]-(4-metil-2-[1,2,3]triazol-2-il-fenil)-metanon;
[(R)-3-(2-fluoro-5-piridazin-3-il-benzil)-morfolin-4-il]-(4-metil-2-[1,2,3]triazol-2-il-fenil)-metanon;
[(2R,3R)-2-metil-3-(3-[1,2,3]triazol-2-il-benzil)-morfolin-4-il]-(5-metil-2-[1,2,3]triazol-2-il-fenil)-metanon;
[(2R,3R)-2-metil-3-(3-[1,2,3]triazol-2-il-benzil)-morfolin-4-il]-(4-metil-2-[1,2,3]triazol-2-il-fenil)-metanon;
[(R)-3-(2-kloro-5-[1,2,3]triazol-2-il-benzil)-morfolin-4-il]-(3,4-dimetil-2-[1,2,3]triazol-2-il-fenil)-metanon;
[(R)-3-(2-kloro-5-[1,2,3]triazol-2-il-benzil)-morfolin-4-il]-(4-kloro-2-[1,2,3]triazol-2-il-fenil)-metanon;
[(R)-3-(2-kloro-5-[1,2,3]triazol-2-il-benzil)-morfolin-4-il]-(3-kloro-2-[1,2,3]triazol-2-il-fenil)-metanon;
(3-kloro-2-[1,2,3]triazol-2-il-fenil)-[(2R,5R)-2-metil-5-(3-[1,2,3]triazol-2-il-benzil)-morfolin-4-il]-metanon;
(3-kloro-2-[1,2,3]triazol-2-il-fenil)-[(2R,5R)-5-(2-fluoro-5-[1,2,3]triazol-2-il-benzil)-2-metil-morfolin-4-il]-metanon;
[(R)-3-(2-fluoro-5-[1,2,4]oksadiazol-3-il-benzil)-morfolin-4-il]-(5-metil-2-[1,2,3]triazol-2-il-fenil)-metanon;
[(R)-3-(2-fluoro-5-[1,2,4]oksadiazol-3-il-benzil)-morfolin-4-il]-(4-metil-2-[1,2,3]triazol-2-il-fenil)-metanon;
(5-kloro-2-[1,2,3]triazol-2-il-fenil)-[(R)-3-(2-fluoro-5-[1,2,4]oksadiazol-3-il-benzil)-morfolin-4-il]-metanon;
[(R)-3-(2-fluoro-5-[1,2,4]oksadiazol-3-il-benzil)-morfolin-4-il]-(3-metil-2-[1,2,3]triazol-2-il-fenil)-metanon;
(4-kloro-2-[1,2,3]triazol-2-il-fenil)-[(R)-3-(2-fluoro-5-[1,2,4]oksadiazol-3-il-benzil)-morfolin-4-il]-metanon;
(4,5-dimetil-2-[1,2,3]triazol-2-il-fenil)-[(R)-3-(2-fluoro-5-[1,2,4]oksadiazol-3-il-benzil)-morfolin-4-il]-metanon;
(3-kloro-2-[1,2,3]triazol-2-il-fenil)-[(R)-3-(2-fluoro-5-[1,2,4]oksadiazol-3-il-benzil)-morfolin-4-il]-metanon;
(3,4-dimetil-2-[1,2,3]triazol-2-il-fenil)-[(R)-3-(2-fluoro-5-[1,2,4]oksadiazol-3-il-benzil)-morfolin-4-il]-metanon;
[(R)-3-(3-[1,2,3]triazol-2-il-benzil)-morfolin-4-il]-(2-[1,2,3]triazol-2-il-3-trifluorometil-fenil)-metanon;
[(R)-3-(2-fluoro-3-[1,2,3]triazol-2-il-benzil)-morfolin-4-il]-(4-metil-2-[1,2,3]triazol-2-il-fenil)-metanon;
(5-kloro-2-[1,2,3]triazol-2-il-fenil)-[(2R,5R)-2-metil-5-(3-[1,2,3]triazol-2-il-benzil)-morfolin-4-il]-metanon;
(4-kloro-2-[1,2,3]triazol-2-il-fenil)-[(2R,5R)-2-metil-5-(3-[1,2,3]triazol-2-il-benzil)-morfolin-4-il]-metanon;
(5-kloro-2-[1,2,3]triazol-2-il-fenil)-[(2R,5R)-5-(2-fluoro-5-[1,2,3]triazol-2-il-benzil)-2-metil-morfolin-4-il]-metanon;
(4-kloro-2-[1,2,3]triazol-2-il-fenil)-[(2R,5R)-5-(2-fluoro-5-[1,2,3]triazol-2-il-benzil)-2-metil-morfolin-4-il]-metanon;
[(R)-3-(2-metil-5-pirazol-1-il-benzil)-morfolin-4-il]-(5-metil-2-[1,2,3]triazol-2-il-fenil)-metanon;
[(R)-3-(2-metil-5-pirazol-1-il-benzil)-morfolin-4-il]-(4-metil-2-[1,2,3]triazol-2-il-fenil)-metanon;
[(R)-3-(2-metil-5-pirazol-1-il-benzil)-morfolin-4-il]-(3-metil-2-[1,2,3]triazol-2-il-fenil)-metanon;
(4-kloro-2-[1,2,3]triazol-2-il-fenil)-[(R)-3-(2-metil-5-[1,2,3]triazol-2-il-benzil)-morfolin-4-il]-metanon;
[(R)-3-(4-metil-3-pirimidin-2-il-benzil)-morfolin-4-il]-(2-[1,2,3]triazol-2-il-fenil)-metanon;
[(R)-3-(4-metil-3-tiazol-2-il-benzil)-morfolin-4-il]-(2-[1,2,3]triazol-2-il-fenil)-metanon; i
[(R)-3-(4-kloro-3-pirimidin-2-il-benzil)-morfolin-4-il]-(2-[1,2,3]triazol-2-il-fenil)-metanon;
ili njegova farmaceutski prihvatljiva sol.
13. Farmaceutski sastav, naznačen time, da kao djelatnu tvar, sadrži jedan ili više spojeva prema bilo kojem od zahtjeva 1 do 12, ili njihovu farmaceutski prihvatljivu sol, te najmanje jedno terapeutski inertno pomoćno sredstvo.
14. Spoj prema bilo kojem od zahtjeva 1 do 12, ili njegova farmaceutski prihvatljiva sol, naznačen/a time, da se upotrebljava kao lijek.
15. Spoj prema bilo kojem od zahtjeva 1 do 12, ili njegova farmaceutski prihvatljiva sol, naznačen/a time, da se upotrebljava u prevenciji ili liječenju bolesti odabrane iz skupine koju čine: anksiozni poremećaji, poremećaji ovisnosti, poremećaji raspoloženja, i poremećaji apetita.
16. Uporaba spoja prema bilo kojem od zahtjeva 1 do 12, ili njegove farmaceutski prihvatljive soli, naznačena time, da je za proizvodnju lijeka za prevenciju ili liječenje bolesti odabrane iz skupine koju čine: anksiozni poremećaji, poremećaji ovisnosti, poremećaji raspoloženja, i poremećaji apetita.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IB2011054976 | 2011-11-08 | ||
EP12791862.1A EP2776430B1 (en) | 2011-11-08 | 2012-11-07 | 2- (1,2,3-triazol-2-yl) benzamide and 3-(1,2,3-triazol-2-yl) picolinamide derivatives as orexin receptor antagonists |
PCT/IB2012/056218 WO2013068935A1 (en) | 2011-11-08 | 2012-11-07 | 2-(1,2,3-triazol-2-yl)benzamide and 3-(1,2,3-triazol-2-yl)picolinamide derivatives as orexin receptor antagonists |
Publications (1)
Publication Number | Publication Date |
---|---|
HRP20160678T1 true HRP20160678T1 (hr) | 2016-07-15 |
Family
ID=47258050
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HRP20160678TT HRP20160678T1 (hr) | 2011-11-08 | 2016-06-14 | Derivati 2-(1,2,3-triazol-2-il)benzamida i 3-(1,2,3-triazol-2-il)pikolinamida kao antagonisti receptora oreksina |
Country Status (28)
Country | Link |
---|---|
US (1) | US9150566B2 (hr) |
EP (1) | EP2776430B1 (hr) |
JP (1) | JP5718535B2 (hr) |
KR (1) | KR101676930B1 (hr) |
CN (1) | CN103917538B (hr) |
AR (1) | AR088692A1 (hr) |
AU (1) | AU2012335194B2 (hr) |
BR (1) | BR112014010617B1 (hr) |
CA (1) | CA2846568C (hr) |
CL (1) | CL2014000659A1 (hr) |
CY (1) | CY1117638T1 (hr) |
DK (1) | DK2776430T3 (hr) |
EA (1) | EA024106B1 (hr) |
ES (1) | ES2572703T3 (hr) |
HK (1) | HK1199022A1 (hr) |
HR (1) | HRP20160678T1 (hr) |
HU (1) | HUE029239T2 (hr) |
IL (1) | IL232462A (hr) |
IN (1) | IN2014CN04127A (hr) |
MX (1) | MX343837B (hr) |
MY (1) | MY167791A (hr) |
PL (1) | PL2776430T3 (hr) |
SG (1) | SG11201401665WA (hr) |
SI (1) | SI2776430T1 (hr) |
TW (2) | TWI555747B (hr) |
UA (1) | UA112317C2 (hr) |
WO (1) | WO2013068935A1 (hr) |
ZA (1) | ZA201404189B (hr) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9440982B2 (en) | 2012-02-07 | 2016-09-13 | Eolas Therapeutics, Inc. | Substituted prolines/piperidines as orexin receptor antagonists |
JP6346862B2 (ja) | 2012-02-07 | 2018-06-20 | エオラス セラピューティクス, インコーポレイテッド | オレキシンレセプターアンタゴニストとしての置換プロリン/ピペリジン |
US9732075B2 (en) | 2012-06-04 | 2017-08-15 | Idorsia Pharmaceuticals Ltd | Benzimidazole-proline derivatives |
WO2014141065A1 (en) | 2013-03-12 | 2014-09-18 | Actelion Pharmaceuticals Ltd | Azetidine amide derivatives as orexin receptor antagonists |
SI3077389T1 (en) | 2013-12-03 | 2018-01-31 | Idorsia Pharmaceuticals Ltd | (S) - (2- (6-CHLORO-7-METHYL-1 H-BENZO (D) IMIDAZOL-2-YL) -2-METHYLPYROLIDIN-1-YL (5-METHOXY-2- (2H- , 2,3-TRIAZOL-2-IL) PHENYL) METHANONE AND ITS USE AS ANTAGONISTS OF OREXIN RECEPTOR |
UA119151C2 (uk) | 2013-12-03 | 2019-05-10 | Ідорсія Фармасьютікалз Лтд | КРИСТАЛІЧНА СОЛЬОВА ФОРМА (S)-(2-(6-ХЛОР-7-МЕТИЛ-1H-БЕНЗО[d]ІМІДАЗОЛ-2-ІЛ)-2-МЕТИЛПІРОЛІДИН-1-ІЛ)(5-МЕТОКСИ-2-(2H-1,2,3-ТРИАЗОЛ-2-ІЛ)ФЕНІЛ)МЕТАНОНУ ЯК АНТАГОНІСТ ОРЕКСИНОВОГО РЕЦЕПТОРА |
WO2015083094A1 (en) | 2013-12-04 | 2015-06-11 | Actelion Pharmaceuticals Ltd | Use of benzimidazole-proline derivatives |
JP2017024990A (ja) * | 2013-12-13 | 2017-02-02 | 大正製薬株式会社 | オキサゾリジン及びオキサジナン誘導体 |
CN105814042B (zh) * | 2013-12-13 | 2018-09-28 | 大正制药株式会社 | 噁嗪烷化合物的晶形及其制造方法 |
US9968624B2 (en) | 2014-05-16 | 2018-05-15 | The University Of Tokyo | Depression treatment agent |
EP3180332B1 (en) | 2014-08-13 | 2021-10-27 | Eolas Therapeutics Inc. | Difluoropyrrolidines as orexin receptor modulators |
WO2016095205A1 (en) | 2014-12-19 | 2016-06-23 | Merck Sharp & Dohme Corp. | Heteroaryl orexin receptor antagonists |
CN104557744B (zh) * | 2014-12-23 | 2017-04-12 | 广东东阳光药业有限公司 | 一种三氮唑化合物的制备方法 |
WO2017088759A1 (en) | 2015-11-23 | 2017-06-01 | Sunshine Lake Pharma Co., Ltd. | OCTAHYDROPYRROLO [3, 4-c] PYRROLE DERIVATIVES AND USES THEREOF |
BR112018016446B1 (pt) | 2016-02-12 | 2024-02-06 | Eolas Therapeutics, Inc. | Composto de piperidina halo-substituída, composição farmacêutica compreendendo dito composto e uso terapêutico dos mesmos |
CA3059394C (en) | 2017-05-03 | 2023-09-12 | Idorsia Pharmaceuticals Ltd | Preparation of 2-([1,2,3]triazol-2-yl)-benzoic acid derivatives |
WO2020099511A1 (en) * | 2018-11-14 | 2020-05-22 | Idorsia Pharmaceuticals Ltd | Benzimidazole-2-methyl-morpholine derivatives |
GB201901142D0 (en) * | 2019-01-28 | 2019-03-20 | Heptares Therapeutics Ltd | OX1 Antagonists |
US20240116913A1 (en) | 2021-02-02 | 2024-04-11 | Idorsia Pharmaceuticals Ltd | A crystalline form of (4-methyl-2-[1,2,3]triazol-2-yl-phenyl)-[(r)-3-(3-[1,2,3]triazol-2-yl-benzyl)-morpholin-4-yl]-methanone |
TW202400149A (zh) * | 2022-05-13 | 2024-01-01 | 瑞士商愛杜西亞製藥有限公司 | 經噻唑并芳基-甲基取代之環狀肼-n-甲醯胺衍生物 |
CN115947697A (zh) * | 2022-12-28 | 2023-04-11 | 苏州汉德创宏生化科技有限公司 | 一种3-氧代吗啉-4-羧酸叔丁酯的合成方法 |
Family Cites Families (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5130432A (en) | 1990-12-21 | 1992-07-14 | Syntex (U.S.A.) Inc. | Process for preparing cyclic amines and intermediate products thereof |
PT100639A (pt) | 1991-06-27 | 1993-09-30 | Univ Virginia Commonwealth | Metodo para o tratamento terapeutico com compostos que sao ligandos ao receptor sigma e compostos ai utilizados, nomeadamente derivados fenilalquil-amina, aminotetralina,piperazina e piperidina |
JP2004534026A (ja) * | 2001-05-05 | 2004-11-11 | スミスクライン ビーチャム パブリック リミテッド カンパニー | オレキシン受容体アンタゴニストとしてのn−アロイルサイクリックアミン誘導体 |
GB0115862D0 (en) | 2001-06-28 | 2001-08-22 | Smithkline Beecham Plc | Compounds |
BR0210609A (pt) * | 2001-06-28 | 2004-07-20 | Smithkline Beecham Plc | Derivados de amina cìclica n-aroila como antagonistas do receptor da orexina |
GB0124463D0 (en) * | 2001-10-11 | 2001-12-05 | Smithkline Beecham Plc | Compounds |
GB0130335D0 (en) | 2001-12-19 | 2002-02-06 | Smithkline Beecham Plc | Compounds |
WO2005118548A1 (en) | 2004-03-01 | 2005-12-15 | Actelion Pharmaceuticals Ltd | Substituted 1,2,3,4-tetrahydroisoquinoline derivatives |
JP4582722B2 (ja) | 2006-03-15 | 2010-11-17 | アクテリオン ファーマシューティカルズ リミテッド | 記憶機能を向上させるテトラヒドロイソキノリン誘導体 |
CA2657623A1 (en) | 2006-07-14 | 2008-01-17 | Merck & Co., Inc. | Bridged diazepan orexin receptor antagonists |
GB0620818D0 (en) | 2006-10-19 | 2006-11-29 | Ucb Sa | Therapeutic agents |
PE20081229A1 (es) | 2006-12-01 | 2008-08-28 | Merck & Co Inc | Antagonistas de receptor de orexina de diazepam sustituido |
CN101874030B (zh) | 2007-09-24 | 2012-11-14 | 埃科特莱茵药品有限公司 | 用作食欲素受体拮抗剂的吡咯烷和哌啶 |
PE20091010A1 (es) | 2007-10-10 | 2009-08-08 | Actelion Pharmaceuticals Ltd | Derivados de tetrahidroquinolina |
CA2739915A1 (en) * | 2008-10-21 | 2010-04-29 | Merck Sharp & Dohme Corp. | 2,5-disubstituted piperidine orexin receptor antagonists |
US8710076B2 (en) | 2008-10-21 | 2014-04-29 | Merck Sharp & Dohme Corp. | 2,5-disubstituted piperidine orexin receptor antagonists |
EP2349270B1 (en) | 2008-10-21 | 2015-09-09 | Merck Sharp & Dohme Corp. | 2,5-disubstituted morpholine orexin receptor antagonists |
BRPI0922353A2 (pt) | 2008-12-02 | 2018-06-05 | Glaxo Group Ltd | Derivados de n-{[(1r,4s, 6r-3- (2-piridinilcarbonil) - 3azabiciclo [4.1.0] hept-4-il] metil}-2-heteroarilamina e usos dos mesmos |
AU2009324239A1 (en) | 2008-12-02 | 2010-06-10 | Glaxo Group Limited | N-{[(IR,4S,6R-3-(2-pyridinylcarbonyl)-3-azabicyclo [4.1.0]hept-4-yl] methyl}-2-heteroarylamine derivatives and uses thereof |
EP2491034B1 (en) | 2009-10-23 | 2013-12-18 | Janssen Pharmaceutica, N.V. | Fused heterocyclic compounds as orexin receptor modulators |
KR20120105449A (ko) | 2009-10-23 | 2012-09-25 | 얀센 파마슈티카 엔.브이. | 오렉신 수용체 조절제로서의 이치환된 옥타하이드로피롤로[3,4-c]피롤 |
WO2011050202A1 (en) | 2009-10-23 | 2011-04-28 | Janssen Pharmaceutica Nv | Fused heterocyclic compounds as orexin receptor modulators |
-
2012
- 2012-11-07 DK DK12791862.1T patent/DK2776430T3/en active
- 2012-11-07 UA UAA201402001A patent/UA112317C2/uk unknown
- 2012-11-07 CN CN201280054325.7A patent/CN103917538B/zh active Active
- 2012-11-07 MY MYPI2014701155A patent/MY167791A/en unknown
- 2012-11-07 US US14/357,159 patent/US9150566B2/en active Active
- 2012-11-07 AU AU2012335194A patent/AU2012335194B2/en not_active Ceased
- 2012-11-07 EA EA201400553A patent/EA024106B1/ru not_active IP Right Cessation
- 2012-11-07 JP JP2014540606A patent/JP5718535B2/ja active Active
- 2012-11-07 BR BR112014010617-7A patent/BR112014010617B1/pt active IP Right Grant
- 2012-11-07 PL PL12791862.1T patent/PL2776430T3/pl unknown
- 2012-11-07 CA CA2846568A patent/CA2846568C/en active Active
- 2012-11-07 AR ARP120104193A patent/AR088692A1/es active IP Right Grant
- 2012-11-07 WO PCT/IB2012/056218 patent/WO2013068935A1/en active Application Filing
- 2012-11-07 EP EP12791862.1A patent/EP2776430B1/en active Active
- 2012-11-07 TW TW101141421A patent/TWI555747B/zh active
- 2012-11-07 KR KR1020147014960A patent/KR101676930B1/ko active IP Right Grant
- 2012-11-07 MX MX2014005635A patent/MX343837B/es active IP Right Grant
- 2012-11-07 TW TW105118634A patent/TWI565703B/zh active
- 2012-11-07 HU HUE12791862A patent/HUE029239T2/en unknown
- 2012-11-07 IN IN4127CHN2014 patent/IN2014CN04127A/en unknown
- 2012-11-07 SI SI201230556A patent/SI2776430T1/sl unknown
- 2012-11-07 SG SG11201401665WA patent/SG11201401665WA/en unknown
- 2012-11-07 ES ES12791862.1T patent/ES2572703T3/es active Active
-
2014
- 2014-03-18 CL CL2014000659A patent/CL2014000659A1/es unknown
- 2014-05-05 IL IL232462A patent/IL232462A/en active IP Right Grant
- 2014-06-06 ZA ZA2014/04189A patent/ZA201404189B/en unknown
- 2014-12-11 HK HK14112452.0A patent/HK1199022A1/zh not_active IP Right Cessation
-
2016
- 2016-06-14 HR HRP20160678TT patent/HRP20160678T1/hr unknown
- 2016-06-15 CY CY20161100527T patent/CY1117638T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HRP20160678T1 (hr) | Derivati 2-(1,2,3-triazol-2-il)benzamida i 3-(1,2,3-triazol-2-il)pikolinamida kao antagonisti receptora oreksina | |
HRP20201171T1 (hr) | Derivati izoindolin-1-ona kao modulatori aktivnosti pozitivnog alosternog modulatora kolinergijskog muskarinskog m1 receptora za liječenje alzheimerove bolesti | |
HRP20141190T1 (hr) | Disupstituirani derivati piridina kao antikancerogena sredstva | |
JP5966014B2 (ja) | 新規トリフルオロメチル−オキサジアゾール誘導体および疾患の処置におけるその使用 | |
RU2439068C2 (ru) | Модуляторы mglur5 | |
HRP20120240T1 (hr) | Piridil piperidin antagonisti receptora za oreksin | |
JP2017513894A5 (hr) | ||
HRP20220314T1 (hr) | Spojevi n-((het)arilmetil)-heteroaril-karboksamida kao plazma kallikrein inhibitori | |
JP2017505293A5 (hr) | ||
JP2014523400A5 (hr) | ||
HRP20161011T1 (hr) | Aril dihidropiridinoni i piperidinoni kao inhibitori mgat2 | |
RU2016133626A (ru) | 2-амино-3,5,5-трифтор-3,4,5,6-тетрагидропиридины в качестве ингибиторов bace1 для лечения болезни альцгеймера | |
WO2013009830A1 (en) | Methods of treatment | |
JP2008513514A5 (hr) | ||
RU2007132262A (ru) | Соединения и композиции в качестве ингибиторов протеинкиназ | |
HRP20140588T1 (hr) | Spojevi kondenziranog prstena i njihova uporaba | |
JP2014511869A5 (hr) | ||
WO2013009827A1 (en) | Methods of treatment | |
RU2008120850A (ru) | Соединения и композиции в качестве ингибиторов протеинкиназ | |
RU2012116877A (ru) | Соединения 2-пиридона, применяемые в качестве ингибиторов нейтрофильной эластазы | |
IL263511A (en) | H1-pyrazolo[4, 3-b]pyridines as pde1 inhibitors | |
HRP20161797T1 (hr) | Spojevi 1,3-oksazolidina ili 1,3-oksazinana kao antagonisti receptora oreksina | |
RU2008135690A (ru) | Соединения и композиции в качестве ингибиторов протеинкиназы | |
RU2019132212A (ru) | Селективные ингибиторы hdac6 | |
RU2017116196A (ru) | 2-амино-6-(дифторметил)-5,5-дифтор-6-фенил-3,4,5,6-тетрагидропиридины как ингибиторы васе1 |